PART I

ITEM 1. FINANCIAL STATEMENTS

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

December 31,
2020

March 31,
2020

ASSETS
Current assets:
Cash and cash equivalents $ 1,255,320 $ 930,856
Accounts receivable, net 1,173,376 990,300
Contract assets 5,314,653 4,504,621
Raw materials 503,636 561,572
Work-in-process 694,848 656,041
Other current assets 442,024 606,151
Total current assets 9,383,857 8,249,541
Property, plant and equipment, net 4,208,329 4,182,861
Deferred income taxes 2,016,816 2,115,480
Other noncurrent assets, net 16,086 32,600
Total assets $ 15,625,088 $ 14,580,482

LIABILITIES AND STOCKHOLDERS’ EQUITY:
Current liabilities:
Accounts payable $ 510,434 $ 185,065
Accrued expenses 1,306,109 1,554,524
Contract liabilities 308,358 805,049
Current portion of long-term debt 3,088,553 109,829
Total current liabilities 5,213,454 2,654,467
Long-term debt 717,559 2,456,560
Commitments and contingent liabilities (Note 13)
Stockholders’ Equity:
Common stock - par value $.0001 per share, 90,000,000 shares authorized, 29,498,662 and 29,354,594 shares issued and outstanding, at December 31, 2020 and March 31, 2020
2,949 2,935
Additional paid in capital 8,911,160 8,793,062
Accumulated other comprehensive income 21,838 21,688
Retained earnings 758,128 651,770
Total stockholders’ equity 9,694,075 9,469,455
Total liabilities and stockholders’ equity $ 15,625,088 $ 14,580,482


	September 30,		March 31,
	2021		2021
ASSETS
Current assets:
Cash and cash equivalents	$	281,315	$	2,130,711
Accounts receivable		2,649,309		608,059
Contract assets		9,306,862		5,532,408
Raw materials		926,524		503,636
Work-in-process		766,007		767,520
Other current assets		611,648		379,437
Total current assets		14,541,665		9,921,771
Property, plant and equipment, net		12,306,401		4,063,209
Right of use asset, net		6,681,160		—
Deferred income taxes		1,986,297		1,934,415
Goodwill		1,174,429		—
Other noncurrent assets, net		—		84,624
Total assets	$	36,689,952	$	16,004,019

LIABILITIES AND STOCKHOLDERS’ EQUITY:
Current liabilities:
Accounts payable	$	2,778,020	$	500,848
Accrued expenses		2,320,893		1,526,270
Contract liabilities		1,113,920		218,152
Current portion lease liability		530,177		—
Current portion of long-term debt		3,790,525		2,474,963
Total current liabilities		10,533,535		4,720,233
Long-term debt, net		3,331,444		1,341,938
Long-term lease liability		6,168,642		—
Total liabilities		20,033,621		6,062,171
Commitments and contingent liabilities (Note 14)
Stockholders’ Equity:
Common stock - par value $.0001 per share, 90,000,000 shares authorized, 34,267,450 and 29,498,662 shares issued and outstanding, at September 30, 2021 and March 31, 2021		3,426		2,949
Additional paid in capital		14,509,086		8,944,660
Accumulated other comprehensive income		20,739		21,838
Retained earnings		2,123,080		972,401
Total stockholders’ equity		16,656,331		9,941,848
Total liabilities and stockholders’ equity	$	36,689,952	$	16,004,019

See accompanying notes to the condensed consolidated financial statements.

3

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) ~~INCOME~~ (unaudited)

Three Months Ended
December 31, Nine Months Ended
December 31,
2020 2019 2020 2019
Net sales $ 3,569,718 $ 3,667,276 $ 11,566,176 $ 11,075,620
Cost of sales 2,864,274 3,352,962 9,034,858 9,238,287
Gross profit 705,444 314,314 2,531,318 1,837,333
Selling, general and administrative 716,361 662,675 2,205,739 2,145,055
(Loss) income from operations (10,917 ) (348,361 ) 325,579 (307,722 )
Other (expense) income (219 ) 185 1,237 21,063
Interest expense (50,405 ) (69,328 ) (159,885 ) (218,447 )
Total other expense, net (50,624 ) (69,143 ) (158,648 ) (197,384 )
(Loss) income before income taxes (61,541 ) (417,504 ) 166,931 (505,106 )
Income tax (benefit) expense (13,369 ) (97,734 ) 60,573 (115,092 )
Net (loss) income $ (48,172 ) $ (319,770 ) $ 106,358 $ (390,014 )
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments $ 1,252 $ 9 $ 151 $ (329 )
Other comprehensive income (loss), net of tax $ 1,252 $ 9 $ 151 $ (329 )
Comprehensive (loss) income $ (46,920 ) $ (319,761 ) $ 106,509 $ (390,343 )
Net (loss) income per share basic $ (0.00 ) $ (0.01 ) $ 0.00 $ (0.01 )
Net (loss) income per share diluted $ (0.00 ) $ (0.01 ) $ 0.00 $ (0.01 )
Weighted average number of shares outstanding: Basic 29,498,662 29,254,594 29,430,206 29,254,230
Diluted 29,498,662 29,254,594 31,021,384 29,254,230


	Three Months Ended				Six Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
Net sales	$	4,797,410	$	4,713,933	$	8,209,639	$	7,996,458
Cost of sales		3,866,703		3,585,073		6,446,264		6,170,584
Gross profit		930,707		1,128,860		1,763,375		1,825,874
Selling, general and administrative		1,173,689		696,016		1,906,297		1,489,378
Income (loss) from operations		(242,982)		432,844		(142,922)		336,496
Other income		1,001		804		11,391		1,456
Interest expense		(56,894)		(51,582)		(86,772)		(109,480)
PPP loan forgiveness		—		—		1,317,100		—
Total other (expense) income		(55,893)		(50,778)		1,241,719		(108,024)
Income (loss) before income taxes		(298,875)		382,066		1,098,797		228,472
Income tax expense (benefit)		(78,462)		111,302		(51,882)		73,942
Net income (loss)	$	(220,413)	$	270,764	$	1,150,679	$	154,530
Other comprehensive loss:
Foreign currency translation adjustments	$	(1,141)	$	(1,005)	$	(1,099)	$	(1,102)
Other comprehensive loss	$	(1,141)	$	(1,005)	$	(1,099)	$	(1,102)
Comprehensive income (loss)	$	(221,554)	$	269,759	$	1,149,580	$	153,428
Net income (loss) per share basic	$	(0.01)	$	0.01	$	0.04	$	0.01
Net income (loss) per share diluted	$	(0.01)	$	0.01	$	0.04	$	0.01
Weighted average shares outstanding - basic		31,359,941		29,431,629		30,424,216		29,395,791
Weighted average shares outstanding - diluted		31,359,941		30,987,233		32,026,262		31,002,130

See accompanying notes to the condensed consolidated financial statements.

4

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)

Common
Stock
Outstanding

Par
Value

Additional
Paid in
Capital

Accumulated
Other
Comprehensive
Income

Retained
Earnings

Total
Stockholders’
Equity

Balance 3/31/2019 29,234,594 $ 2,923 $ 8,693,106 $ 21,940 $ 993,339 $ 9,711,308
Stock-based compensation 30,625 30,625
Shares issued under LTIP 20,000 2 7,198 7,200
Net income 220,777 220,777
Currency translation adjustment (179 ) (179 )
Balance 6/30/2019 29,254,594 $ 2,925 $ 8,730,929 $ 21,761 $ 1,214,116 $ 9,969,731
Stock-based compensation 30,625 30,625
Net loss (291,021 ) (291,021 )
Currency translation adjustment (159 ) (159 )
Balance 9/30/2019 29,254,594 $ 2,925 $ 8,761,554 $ 21,602 $ 923,095 $ 9,709,176
Stock-based compensation 20,417 20,417
Net loss (319,770 ) (319,770 )
Currency translation adjustment 9 9
Balance 12/31/2019 29,254,594 $ 2,925 $ 8,781,971 $ 21,611 $ 603,325 $ 9,409,832

Balance 3/31/2020 29,354,594 $ 2,935 $ 8,793,062 $ 21,688 $ 651,770 $ 9,469,455
Stock-based compensation 55,500 55,500
Shares issued under LTIP 44,068 4 (4 ) --
Net loss (116,234 ) (116,234 )
Currency translation adjustment (97 ) (97 )
Balance 6/30/2020 29,398,662 $ 2,939 $ 8,848,558 $ 21,591 $ 535,536 $ 9,408,624
Stock-based compensation 57,417 57,417
Restricted stock award 100,000 10 133,990 134,000
Non-vested restricted stock (134,000 ) (134,000 )
Net income 270,764 270,764
Currency translation adjustment (1,005 ) (1,005 )
Balance 9/30/2020 29,498,662 $ 2,949 $ 8,905,965 $ 20,586 $ 806,300 $ 9,735,800
Stock-based compensation 33,500 33,500
Taxes on exercised options (28,305 ) (28,305 )
Net loss (48,172 ) (48,172 )
Currency translation adjustment 1,252 1,252
Balance 12/31/2020 29,498,662 $ 2,949 $ 8,911,160 $ 21,838 $ 758,128 $ 9,694,075


						Accumulated
	Common			Additional		Other				Total
	Stock	Par		Paid in		Comprehensive		Retained		Stockholders’
	Outstanding	Value		Capital		Income		Earnings		Equity
Balance 3/31/2020	29,354,594	$	2,935	$	8,793,062	$	21,688	$	651,770	$	9,469,455
Stock-based compensation					55,500						55,500
Shares issued under LTIP	44,068		4		(4)						—
Net loss									(116,234)		(116,234)
Foreign currency translation adjustment							(97)				(97)
Balance 6/30/2020	29,398,662	$	2,939	$	8,848,558	$	21,591	$	535,536	$	9,408,624
Stock-based compensation					57,417						57,417
Restricted stock award	100,000		10		(10)						—
Net income									270,764		270,764
Foreign currency translation adjustment							(1,005)				(1,005)
Balance 9/30/2020	29,498,662	$	2,949	$	8,905,965	$	20,586	$	806,300	$	9,735,800

Balance 3/31/2021	29,498,662	$	2,949	$	8,944,660	$	21,838	$	972,401	$	9,941,848
Stock-based compensation					33,500						33,500
Net income									1,371,092		1,371,092
Foreign currency translation adjustment							42				42
Balance 6/30/2021	29,498,662	$	2,949	$	8,978,160	$	21,880	$	2,343,493	$	11,346,482
Restricted stock award	100,000		10		(10)						—
Common stock issued for acquired business	1,466,061		147		2,268,853						2,269,000
Proceeds from sale of common stock, net	3,202,727		320		3,187,260						3,187,580
Issuance of warrants					46,256						46,256
Stock-based compensation					28,566						28,566
Net loss							��		(220,413)		(220,413)
Foreign currency translation adjustment							(1,141)				(1,141)
Balance 9/30/2021	34,267,450	$	3,426	$	14,509,086	$	20,739	$	2,123,080	$	16,656,331

See accompanying notes to the condensed consolidated financial statements.

5

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

Nine Months Ended December 31,
2020 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss) $ 106,358 $ (390,014 )
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation 521,422 548,038
Amortization of debt issue costs 45,099 31,280
Stock based compensation expense 146,417 81,667
Change in contract loss provision (175,365 ) 216,039
Deferred income taxes 60,573 (115,092 )
Changes in operating assets and liabilities:
Accounts receivable (183,076 ) 257,459
Contract assets (810,032 ) (271,767 )
Inventories 19,129 589,904
Other current assets 164,127 (296,328 )
Other noncurrent assets 38,092 (9,419 )
Accounts payable 325,369 (138,463 )
Accrued expenses (101,028 ) 18,282
Contract liabilities (496,691 ) 87,815
Net cash (used in) provided by operating activities (339,606 ) 609,401
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment (546,890 ) (35,225 )
Net cash used in investing activities (546,890 ) (35,225 )
CASH FLOWS FROM FINANCING ACTIVITIES
Debt issue costs (24,610 ) (32,209 )
Proceeds from payroll protection program loan 1,317,100 --
Proceeds from revolver loan 1,000,000 --
Repayment of revolver loan (1,000,000 ) --
Repayment of long-term debt (81,352 ) (610,515 )
Net cash provided by (used in) financing activities 1,211,138 (642,724 )
Effect of exchange rate on cash and cash equivalents (178 ) 307
Net increase (decrease) in cash and cash equivalents 324,464 (68,241 )
Cash and cash equivalents, beginning of period 930,856 2,036,646
Cash and cash equivalents, end of period $ 1,255,320 $ 1,968,405
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION
Cash paid during the year for:
Interest (net of amounts capitalized) $ 106,342 $ 187,085
Income taxes $ -- $ --


	Six Months Ended September 30,
	2021		2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	1,150,679	$	154,530
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		515,804		339,232
Amortization of debt issue costs		18,096		31,086
Stock based compensation expense		62,066		112,917
Change in contract loss provision		(100,497)		(49,553)
Deferred income taxes		(51,882)		73,942
PPP loan forgiveness		(1,317,100)		—
Changes in operating assets and liabilities:
Accounts receivable		(794,235)		(388,317)
Contract assets		56,153		(1,475,912)
Inventories		505,814		126,457
Other current assets		141,765		320,847
Accounts payable		(403,159)		25,308
Accrued expenses		(1,588,991)		158,791
Contract liabilities		739,043		(168,854)
Net cash used in operating activities		(1,066,444)		(739,526)
CASH FLOWS FROM INVESTING ACTIVITIES:
Business acquisition, net of cash acquired		(7,795,810)		—
Purchases of property, plant and equipment		(362,986)		(354,788)
Net cash used in investing activities		(8,158,796)		(354,788)
CASH FLOWS FROM FINANCING ACTIVITIES:
Closing costs related to common stock sale		(335,419)		—
Proceeds from sale of common stock		3,523,000		—
Proceeds from term loan		4,000,000		—
Debt issue costs		(109,532)		(8,282)
Proceeds from payroll protection program loan		—		1,317,100
Revolver loan borrowings		865,049		—
Payments of principal for leases		(475,440)		—
Repayments long-term debt		(91,781)		(53,614)
Net cash provided by financing activities		7,375,877		1,255,204
Effect of exchange rate on cash and cash equivalents		(33)		(133)
Net (decrease) increase in cash and cash equivalents		(1,849,396)		160,757
Cash and cash equivalents, beginning of period		2,130,711		930,856
Cash and cash equivalents, end of period	$	281,315	$	1,091,613
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION:
Cash paid for interest, net of amounts capitalized	$	83,616	$	78,834

See accompanying notes to the condensed consolidated financial statements.

6

Table of Contents

SUPPLEMENTAL INFORMATION -– NONCASH INVESTING AND FINANCING TRANSACTIONS:

~~Nine~~Six months ended ~~December 31,~~September 30, 2021 and 2020

On August 25, 2021 the Company acquired all of the issued and outstanding capital stock of Stadco in exchange for the issuance of 1,466,061 shares of common stock and warrants. Consideration transferred was $2,269,000 and based on the closing market price of the Company’s common stock on the closing date, August 25, 2021.

In connection with the Stadco acquisition, the Company became party to an amended and restated lease agreement to rent buildings and property at the Stadco manufacturing location, and recorded a right-of-use asset and liability of approximately $6.7 million.

On June 16, 2020, our executive officers exercised options to purchase 150,000 shares of the Company’s common stock, par value $0.0001 per share, in a cashless transaction, pursuant to option awards granted under the Company’s 2016 Long-Term Incentive Plan.

7

Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 1 - DESCRIPTION OF BUSINESS

TechPrecision Corporation, or TechPrecision, is a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. The name was changed to TechPrecision Corporation on March 6, 2006. TechPrecision is the parent company of Ranor, Inc., or Ranor, ~~a Delaware corporation,~~Westminster Credit Holdings, LLC, or WCH, Stadco New Acquisition, LLC, or Acquisition Sub, Stadco and Wuxi Critical Mechanical Components Co., Ltd., or WCMC, a wholly foreign owned enterprise. WCMC has no customers or operations, and we have initiated a plan of termination to legally dissolve this subsidiary. TechPrecision, Ranor, WCH, WCMC, Acquisition Sub and ~~Ranor~~Stadco are collectively referred to as the “Company”, “we”, “us” or “our”.

On August 25, 2021, pursuant to the stock purchase agreement among TechPrecision, Acquisition Sub, Stadco and certain affiliates of Stadco, TechPrecision completed its previously announced acquisition of Stadco. Stadco is a company in the business of manufacturing high-precision parts, assemblies and tooling for aerospace, defense, research and industrial customers. See Note 3 below for more information regarding the Stadco acquisition.

~~We manufacture~~The Company manufactures large-scale metal fabricated and machined precision components and equipment. These products are used in a variety of markets including defense, ~~and~~ aerospace, nuclear, medical, and precision industrial. We consider our business to consist of one segment - metal fabrication and precision machining. All of our operations and customers are located in the United States.

NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Consolidation - The accompanying condensed consolidated financial statements include the accounts of TechPrecision, Ranor, WCH, WCMC, Acquisition Sub and ~~WCMC.~~Stadco. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheets as of ~~December 31, 2020 and March 31, 2020,~~September 30, 2021, the condensed consolidated statements of operations and comprehensive income (loss) ~~income~~ and stockholders’ equity for the three and ~~nine~~six months ended ~~December 31,~~September 30, 2021 and 2020, ~~and 2019,~~ and the condensed consolidated statements of cash flows for the ~~nine~~six months ended ~~December 31,~~September 30, 2021 and 2020 ~~and 2019~~ are unaudited, but, in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

These notes to the condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for Quarterly Reports on Form 10-Q. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with the consolidated financial statements included with our Annual Report on Form 10-K for the fiscal year ended March 31, ~~2020,~~2021, or the ~~2020~~2021 Form 10-K, filed with the SEC on June ~~11, 2020.~~10, 2021.

Use of Estimates in the Preparation of Financial Statements -In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and revenues and expenses during the reported period. We continually evaluate our estimates, including those related to business combinations, contract accounting, accounts receivable, inventories, the recovery of long-lived assets, income taxes and the valuation of equity transactions. We base our estimates on historical and current experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.

8

Table of Contents

Accounting for Goodwill – The Company allocates the purchase price of an acquired company, including, when applicable, the acquisition date fair value of contingent consideration, between tangible and intangible assets acquired and liabilities assumed from the acquired business based on their estimated fair values, with the residual of the purchase price recorded as goodwill.

Goodwill of a reporting unit is not amortized, but tested for impairment at least annually, or on an interim basis whenever circumstances indicate that the carrying value of these assets may not be recoverable. A goodwill impairment charge would reflect the amount by which the carrying amount of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill.

The ~~COVID-19 pandemic~~Company has ~~negatively affected~~not formed a conclusion on the issue of tax deductibility for goodwill. We are evaluating certain ~~customers, suppliers~~tax election options under the Stadco stock purchase agreement and ~~their labor force. For example, travel restrictions~~will make a determination as soon as practicable.

NOTE 3 – BUSINESS COMBINATION

On August 25, 2021, the closing date, the Company completed its previously announced acquisition of Stadco, pursuant to the stock purchase agreement, dated as of October 16, 2020, among TechPrecision, Acquisition Sub, Stadco Acquisition, LLC, or Holdco, and each stockholder of Holdco, or the SPA. Stadco is a company in the business of manufacturing high-precision parts, assemblies and tooling for aerospace, defense, and industrial customers.

Also on the closing date, the Company completed its previously announced acquisition of certain indebtedness obligations of Stadco, pursuant to that certain Amended and Restated Loan Purchase and Sale Agreement, dated as of April 23, 2021, with Sunflower Bank, N.A., as amended by Amendment to Amended and Restated Loan Purchase and Sale Agreement, dated as of June 28, 2021, together, the Loan Purchase Agreement. On August 25, 2021, WCH, as assignee of Acquisition Sub, paid $7.9 million in the aggregate to Sunflower Bank, N.A., under the terms of the Loan Purchase Agreement, to purchase the indebtedness.

Pursuant to the SPA, and upon the terms and subject to the conditions therein, the Company acquired all of the issued and outstanding capital stock of Stadco in exchange for the issuance of 666,666 shares of the Company’s common stock to Holdco. In connection with the ~~pandemic have delayed inspections, deliveries and impacted some supply chain providers. The future financial impact~~acquisition of Stadco, the Company reached an agreement with the holders of certain other non-bank indebtedness of Stadco, under which each such lender agreed to forgive such indebtedness in exchange for an aggregate of 199,395 shares of the ~~COVID-19 pandemic cannot~~Company’s common stock. In addition, the Company reached an agreement with a certain other security holder who agreed to sell its Stadco securities to the Company in exchange for the issuance by the Company of 600,000 shares of the Company’s common stock and a warrant to purchase 100,000 shares of the Company’s common stock. The fair value of the 1,466,061 shares of common stock issued as consideration transferred was $2.3 million based on the closing market price of the Company’s common stock on the August 25, 2021 closing date.

On August 25, 2021, the Company entered into a Securities Purchase Agreement with a limited number of institutional and other accredited investors, pursuant to which investors committed to subscribe for and purchase 3,202,727 shares of the Company’s common stock at a purchase price of $1.10. Costs directly attributable to this offering of securities totaled $0.3 million.

The accounting for a business combination is dependent upon obtaining valuations and other information for certain assets and liabilities which have not yet been completed or obtained to a point where definitive estimates can be ~~reasonably~~made. The process for estimating the fair values of identified intangible assets, certain tangible assets and assumed liabilities require the use of judgment to determine the appropriate assumptions. Until the Company finalizes estimates of the fair value of assets acquired and liabilities assumed substantially all of the purchase price allocation for Stadco is provisional. Additional purchase price adjustments will be recorded during the measurement period not to exceed one year beyond the acquisition date. These adjustments may have a material impact on the Company’s results of operations and financial position.

9

Table of Contents

Included in the total consideration transferred is $113,890 related to a contingent provision in the agreements based on the difference between the TechPrecision stock price and contract target stock price. The contingent provision allows the issuer, TechPrecision, to settle the contingency with stock or cash, or a combination of each. If after one year following the closing of the acquisition, the fair value of the consideration stock is less than the target stock price stated in each agreement, TechPrecision will issue to the holder additional shares of consideration stock or cash, or some combination of stock and cash. The target stock price stated in the agreements are guaranteed, only the number of shares issued can vary, with the final measurement date and amount to be determined on the one-year anniversary date. Since the contract does not specify a fixed maximum number of shares to be issued on the anniversary date, should the company determine to satisfy the contingent consideration with shares, then a number of shares higher than the amount currently authorized by the company’s certificate of incorporation may be required to be issued. In any case, the maximum value of the contingent consideration will be $2,269,000, whether paid in shares of common stock or in cash, or both. The estimated liability associated with the contingent consideration had a 0 balance at ~~this time~~September 30, 2021.

The table below presents the provisional estimated fair value of assets acquired and liabilities assumed on the acquisition date based on the best information it has received to date, in accordance with Accounting Standards Codification, or ASC, 805. Acquisition related costs totaled approximately $320,000 and are included under general and administrative expenses in our statement of operations. The allocation of the purchase price of the Stadco acquisition is not complete and the amounts below represent the Company’s best estimate of fair value:


Total consideration transferred	$	10,163,164
Recognized amounts of identifiable assets acquired and liabilities assumed:
Accounts receivable	$	1,247,015
Inventory and other current assets		5,250,781
Property, plant and equipment including right of use assets		15,074,273
Accounts payable, accrued expenses, and other current liabilities		(5,882,048)
Lease obligations		(6,701,286)
Net assets	$	8,988,735
Goodwill		1,174,429
Total	$	10,163,164

Supplemental Pro Forma Information

The pro forma results presented below were prepared as ~~its~~if the acquisition had been consummated on April 1, 2020. The pro forma results have been prepared for comparative purposes only and do not necessarily represent what the revenue or results of operations would have been had the acquisition been completed on April 1, 2020. In addition, these results are not intended to be a projection of future operating results and do not reflect synergies that might be achieved from the acquisition.

The pro forma results include adjustments for the estimated purchase accounting impact, ~~depends on future developments,~~including, but not limited to, depreciation and amortization associated with the acquired tangible and intangible assets, and an adjustment for interest expense related to the new long-term debt, the alignment of accounting policies, and the elimination of transactions between TechPrecision and Stadco.

Other adjustments reflected in the pro forma results are as follows:

•

For the three and six months ended September 30, 2020, we excluded $1.0 million from cost of goods sold, the net change in depreciation and amortization resulting from a reversal of amortization for an asset deemed to have zero fair value based on revaluation of the Stadco intangible assets upon TechPrecision Corporation’s acquisition of Stadco. This amount was partially offset by depreciation and amortization resulting from a valuation adjustment to Stadco’s property, plant and equipment of $7.1 million plus the recognition of the right-of-use asset for Stadco’s property lease in the amount of $6.6 million against the reversal of historical rent expense

•

For the three and six months ended September 30, 2021 and 2020, we excluded $0.7 million of management fees due to then preferred stockholders of Stadco

10

Table of Contents

•

For the three and six months ended September 30, 2021 and 2020, we excluded interest expense by $0.5 million, reflecting a reduction of Stadco’s bank debt and interest rates.

The following table discloses the actual results of Stadco since the August 25, 2021 acquisition which are ~~highly uncertain~~included in the Company’s condensed consolidated financial statements. Also presented in the table below are pro forma results for the combined entities, assuming the acquisition date had occurred on April 1, 2020, for the three and ~~cannot~~six months ended September 30, 2021 and 2020:


	Stadco only		Pro forma combined
	Actual August 26, 2021		Three months ended		Six months ended		Three months ended		Six months ended
	– September 30,		September 30,		September 30,		September 30,		September 30,
	2021		2021		2021		2020		2020
Net sales	$	1,258,626	$	5,094,151	$	12,929,679	$	8,196,026	$	14,961,345
Operating income (loss)	$	64,809	$	(1,579,777)	$	(1,936,097)	$	350,441	$	182,568
Income (loss) before income taxes	$	22,113	$	(1,832,508)	$	(954,261)	$	199,520	$	(139,609)
Net income (loss)			$	(1,753,993)	$	(903,274)	$	86,458	$	(215,311)
EPS basic			$	(0.05)	$	(0.03)	$	0.00	$	(0.01)
EPS dilutive			$	(0.05)	$	(0.03)	$	0.00	$	(0.01)
Weighted average shares outstanding – basic				34,181,736		34,174,554		34,100,059		34,064,579
Weighted average shares outstanding - diluted				34,181,736		34,174,554		35,638,754		34,064,579

NOTE 4 - REVENUE

The Company generates revenue primarily from performance obligations completed under contracts with customers in two main market sectors: defense and precision industrial. The period over which the Company performs its obligations can be ~~predicted.~~between three and thirty-six months.

~~The directives imposed by federal, state~~Revenue is recognized over-time or at a point-in-time given the terms and ~~local governments as a result~~conditions of the ~~COVID-19 pandemic did not impair our ability~~related contracts. The Company utilizes an inputs methodology based on estimated labor hours to ~~maintain operations during~~measure performance progress. This model best depicts the ~~first nine months~~transfer of ~~fiscal~~control to the customer.

The Company’s contract portfolio is comprised of fixed-price contracts and provide for product type sales only. The following table presents net sales on a disaggregated basis by market and contract type:


Net Sales by market	Defense		Industrial		Totals
Three months ended September 30, 2021	$	4,403,156	$	394,254	$	4,797,410
Three months ended September 30, 2020	$	3,225,503	$	1,488,430	$	4,713,933
Six months ended September 30, 2021	$	7,506,287	$	703,352	$	8,209,639
Six months ended September 30, 2020	$	6,429,093	$	1,567,365	$	7,996,458


Net Sales by contract type	Over-time		Point-in-time		Totals
Three months ended September 30, 2021	$	3,757,988	$	1,039,422	$	4,797,410
Three months ended September 30, 2020	$	3,081,971	$	1,631,962	$	4,713,933
Six months ended September 30, 2021	$	6,880,637	$	1,329,002	$	8,209,639
Six months ended September 30, 2020	$	6,109,868	$	1,886,590	$	7,996,458

As of September 30, 2021, as the Company ~~was designated an essential service. Our estimates~~had $26.4 million of remaining performance obligations, of which $17.1 million were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue within the next thirty-six months.

11

Table of Contents

We are dependent each year on a small number of customers who generate a significant portion of our business, and these customers change from year to year. The following table sets forth revenues from customers who accounted for more than 10% of our net sales.


	Three months ended				Three months ended				Six months ended				Six months ended
	September 30, 2021				September 30, 2020				September 30, 2021				September 30, 2020
Customer	Amount		Percent		Amount		Percent		Amount		Percent		Amount		Percent
A	$	1,175,893	25	%	$	499,921	11	%	$	2,479,665	30	%	$	1,070,701	13	%
B	$	721,405	15	%	$	686,486	15	%	$	1,660,261	20	%	$	1,340,673	17	%
C	$	648,954	14	%	$	459,441	10	%	$	938,534	11	%	$	*	*	%
D	$	*	*	%	$	726,921	15	%	$	*	*	%	$	*	*	%
E	$	*	*	%	$	694,332	15	%	$	*	*	%	$	1,708,987	21	%
F	$	*	*	%	$	575,315	12	%	$	*	*	%	$	*	*	%
G	$	*	*	%	$	558,160	12	%	$	*	*	%	$	948,672	12	%

*Less than 10% of total

In our condensed consolidated balance sheet, contract assets and contract liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. For the ~~first nine~~six months ended September 30, 2021, we recognized revenue of ~~fiscal~~less than $0.2 million related to our contract liabilities at April 1, 2021. Contract assets consisted of the following at:


			Progress
	Unbilled		payments		Total
September 30, 2021	$	12,725,048	$	(3,418,186)	$	9,306,862
March 31, 2021	$	11,392,948	$	(5,860,540)	$	5,532,408

NOTE 5 - INCOME TAXES

The Company accounts for income taxes under ASC 740, Income Taxes. The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items. The income tax benefit for the three and six months ended September 30, 2021 ~~assumed no material impact~~was $78,462 and $51,882. The Company’s effective tax rate for the three and six months ended September 30, 2021 was 26.3% and 5.0%, respectively. The Company’s effective tax rate for the six months ended September 30, 2021 was lower due to the nontaxable loan forgiveness item of $1.3 million disclosed in the condensed consolidated statement of operations. Income tax expense for the three and six months ended September 30, 2020 was $111,302 and $73,942.

The valuation allowance on deferred tax assets was approximately $1.8 million at September 30, 2021. We believe that it is more likely than not that the benefit from certain state and foreign net operating losses, or NOL, carryforwards and other deferred tax assets will not be realized. In the ~~disruptions caused by COVID-19.~~event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

12

Table of Contents

~~NOTE 3 – ACCOUNTING STANDARDS UPDATE~~

~~New Accounting Standards Recently Adopted~~

~~On April 1, 2020 we adopted ASU 2018-13,~~ ~~Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.~~ This ASU modifies the disclosure requirements in Topic 820 by removing, modifying or adding certain disclosures. The amendments for changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are applied prospectively. All other amendments are applied retrospectively to all periods presented upon their effective date. The adoption did not have a significant impact on our consolidated financial statement disclosures.

~~Issued Standards Not Yet Adopted~~

~~In December, 2019, the Financial Accounting Standards Board (FASB) issued ASU No. 2019-12,~~ ~~Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes~~, expected to reduce cost and complexity related to the accounting for income taxes. This ASU removes specific exceptions to the general principles in Topic 740 under U.S. GAAP and removes the limitation on the tax benefit recognized on pre-tax losses in interim periods. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company plans to adopt the standard on April 1, 2021, and is currently evaluating the amendments in this update to determine the impact it may have on its financial statements and disclosures.

~~NOTE 4 - REVENUE~~

The Company generates its revenues primarily from performance obligations completed under contracts with customers in two main market sectors: defense and precision industrial. The period over which the Company performs its obligations can range from three to thirty-six months. The Company invoices and receives related payments based upon performance progress not less frequently than monthly.

Revenue is recognized over-time or at a point-in-time given the terms and conditions of the related contracts. The Company utilizes an inputs methodology based on estimated labor hours to measure performance progress. This model best depicts the transfer of control to the customer.

The Company’s contract portfolio is comprised of fixed-price contracts and provides for product type sales only. The following table presents net sales on a disaggregated basis by market and contract type:

Net Sales by market Defense Industrial Totals
Three months ended December 31, 2020 $ 2,885,753 $ 683,965 $ 3,569,718
Three months ended December 31, 2019 $ 3,200,671 $ 466,605 $ 3,667,276
Nine months ended December 31, 2020 $ 9,314,846 $ 2,251,330 $ 11,566,176
Nine months ended December 31, 2019 $ 9,725,635 $ 1,349,985 $ 11,075,620

Net Sales by contract type Over-time Point-in-time Totals
Three months ended December 31, 2020 $ 3,141,416 $ 428,302 $ 3,569,718
Three months ended December 31, 2019 $ 3,439,367 $ 227,909 $ 3,667,276
Nine months ended December 31, 2020 $ 9,251,284 $ 2,314,892 $ 11,566,176
Nine months ended December 31, 2019 $ 9,104,395 $ 1,971,225 $ 11,075,620

As of December 31, 2020, the Company had $18.4 million of remaining performance obligations, of which $13.0 million were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue over-time or at a point-in-time during the next thirty-six months.

We have been dependent in each year on a small number of customers who generate a significant portion of our business, and these customers can change from year to year. The following table presents customers who accounted for 10% or more of our net sales for the following periods:

Three months ended
December 31, 2020 Three months ended
December 31, 2019 Nine months ended
December 31, 2020 Nine months ended
December 31, 2019
Customer Amount Percent Amount Percent Amount Percent Amount Percent
A $ 398,011 11 % $ 404,062 11 % $ 2,106,998 18 % $ 1,790,311 16 %
B $ 530,583 15 % $ * * % $ 1,871,256 16 % $ * * %
C $ 609,114 17 % $ 1,215,737 33 % $ 1,679,814 15 % $ 2,320,485 21 %
D $ 682,337 19 % $ 727,084 20 % $ 1,631,010 14 % $ 1,825,213 16 %
E $ 550,096 15 % $ * * % $ * * % $ * * %
F $ * * % $ * * % $ * * % $ 1,136,146 10 %
G $ * * % $ * * % $ * * % $ 1,148,242 10 %

*Less than 10% of total

On our condensed consolidated balance sheet, contract assets and contract liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. In fiscal 2021, we recognized revenue of $0.8 million related to our contract liabilities at March 31, 2020. At December 31, 2020 contract assets consisted of the following:

Contract assets Unbilled Less:Progress
payments Total
December 31, 2020 $ 10,074,902 $ 4,760,249 $ 5,314,653
March 31, 2020 $ 10,635,588 $ 6,130,967 $ 4,504,621

~~NOTE 5 - INCOME TAXES~~

We account for income taxes under the provisions of FASB ASC 740, Income Taxes. The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items. The income tax provision for the nine months ended December 31, 2020 was $60,573, the income tax benefit for the nine months ended December 31, 2019 was $115,092. The Company's estimated effective tax rate for the nine months ended December 31, 2020 was 36.3%.

The valuation allowance on deferred tax assets was approximately $1.7 million at December 31, 2020. We believe that it is more likely than not that the benefit from certain state and foreign net operating losses, or NOL, carryforwards and other deferred tax assets will not be realized. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

NOTE 6 - EARNINGS PER SHARE

Basic earnings per share, or EPS, is computed by dividing reported earnings available to stockholders by the weighted average number of shares outstanding. Diluted ~~earnings per share~~EPS also includes the effect of stock options that would be dilutive. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share ~~computations, as required under FASB ASC 260.~~computations:

Three months ended
December 31, 2020 Three months ended
December 31, 2019 Nine months ended
December 31, 2020 Nine months ended
December 31, 2019
Basic EPS:
Net (loss) income $ (48,172 ) $ (319,770 ) $ 106,358 $ (390,014 )
Weighted average shares 29,498,662 29,254,594 29,430,206 29,254,230
Basic (loss) income per share $ (0.00 ) $ (0.01 ) $ 0.00 $ (0.01 )
Diluted EPS:
Net (loss) income $ (48,172 ) $ (319,770 ) $ 106,358 $ (390,014 )
Dilutive effect of stock options -- -- 1,591,178 --
Diluted weighted average shares 29,498,662 29,254,594 31,021,384 29,254,230
Diluted (loss) income per share $ (0.00 ) $ (0.01 ) $ 0.00 $ (0.01 )


	Three Months ended		Three Months ended		Six Months ended		Six Months ended
	September 30, 2021		September 30, 2020		September 30, 2021		September 30, 2020
Basic EPS
Net income (loss)	$	(220,413)	$	270,764	$	1,150,679	$	154,530
Weighted average shares		31,359,941		29,431,629		30,424,216		29,395,791
Net income (loss) per share	$	(0.01)	$	0.01	$	0.04	$	0.01
Diluted EPS
Net income (loss)	$	(220,413)	$	270,764	$	1,150,679	$	154,530
Dilutive effect of stock options		—		1,555,604		1,602,046		1,606,339
Weighted average shares		31,359,941		30,987,233		32,026,262		31,002,130
Net income (loss) per share	$	(0.01)	$	0.01	$	0.04	$	0.01

All of the restricted stock issued in September 2021 is included in the weighted average basic and diluted shares calculation. All potential common stock equivalents that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted ~~earnings per share.~~EPS. For the three months ended ~~December 31, 2020~~September 30, 2021, there were ~~2,814,000~~1,660,922 of potentially anti-dilutive stock options and warrants, none of which were included in the ~~EPS calculations above. For the nine months ended December 31, 2020, there were 94,000 of common stock equivalents that were out-of-the-money and not included in the above~~ earnings per share calculations. ~~For the three and nine months ended December 31, 2019, there were 2,967,000 of potentially anti-dilutive stock options, none of which were included in the EPS calculations above.~~

NOTE 7 -– STOCK-BASED COMPENSATION

Our board of directors, upon the recommendation of the compensation committee of our board of directors, approved the 2016 TechPrecision Equity Incentive Plan, or the 2016 Plan, on November 10, 2016. Our stockholders approved the 2016 Plan at the Company’s Annual Meeting of Stockholders on December 8, 2016. The 2016 Plan succeeds the 2006 Long-Term Incentive Plan, or the 2006 Plan, and applies to awards granted after the 2016 Plan’s adoption by the Company’s stockholders. ~~The 2016 Plan provides for a share reserve of 5,000,000 shares of common stock.~~

The 2016 Plan authorizes the award of incentive and non-qualified stock options, restricted stock awards, restricted stock units, and performance awards to employees, directors, consultants, and other individuals who provide services to TechPrecision or its affiliates. The purpose of the 2016 Plan is to: (a) enable TechPrecision and its affiliated companies to recruit and retain highly qualified employees, directors and consultants; (b) provide those employees, directors and consultants with an incentive for productivity; and (c) provide those employees, directors and consultants with an opportunity to share in the growth and value of the Company. Subject to adjustment as provided in the 2016 Plan, the maximum number of shares of common stock that may be issued with respect to awards under the 2016 Plan is 5,000,000 shares (inclusive of awards issued under the 2006 Plan, that remained outstanding as of the effective date of the 2016 Plan). Shares of our common stock subject to awards that expire unexercised or are otherwise forfeited shall again be available for awards under the 2016 Plan.

On June 16, 2020, our executive officers exercised options to purchase 150,000 shares of the Company’s common stock, par value $0.0001 per share, in a cashless transaction, pursuant to option awards granted under the Company’s 2016 Long-Term Incentive Plan.

13

Table of Contents

At ~~December 31, 2020~~September 30, 2021, there were ~~1,376,000~~1,370,000 shares available for grant under the 2016 Plan. The following table summarizes information about ~~stock option activity:~~options granted during the most recently completed periods:

	Number Of			Weighted Average		Aggregate Intrinsic		Weighted Average Remaining Contractual Life
	Options			Exercise Price		Value		(in years)
Outstanding at 3/31/2019		2,938,000		$	0.416	$	1,869,200		6.74

															Weighted
															Average
											Weighted		Aggregate		Remaining
										Number Of	Average		Intrinsic		Contractual Life
										Options	Exercise Price		Value		(in years)
Outstanding at 3/31/2020										2,916,000	$	0.415	$	2,546,800	6.21
Exercised		(20,000	)		0.360					(150,000)		0.800
Canceled		(2,000	)							(47,000)
Outstanding at 3/31/2020		2,916,000		$	0.415	$	2,546,800		6.21
Outstanding at 3/31/2021										2,719,000	$	0.372	$	2,476,300	5.62
Canceled		(2,000	)							(49,000)
Exercised		(150,000	)		0.800
Outstanding at 12/31/2020		2,764,000		$	0.393	$	2,743,300		5.81
Vested or expected to vest at 12/31/2020		2,764,000		$	0.393	$	2,743,300		5.81
Exercisable and vested at 12/31/2020		2,764,000		$	0.393	$	2,743,300		5.81
Vested or expected to vest at 9/30/2021										2,670,000	$	0.343	$	4,372,000	5.14
Exercisable and vested at 9/30/2021										2,670,000	$	0.343	$	4,372,000	5.14

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the ~~third~~second quarter of fiscal ~~2021~~2022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on ~~December 31, 2020.~~September 30,2021. This amount changes based on the fair market value of the Company’s common stock.

At ~~December 31, 2020,~~September 30,2021, there was no0 remaining unrecognized compensation cost related to stock options. The maximum contractual term is ten years for option grants. Other information relating to stock options outstanding at ~~December 31, 2020~~September 30,2021 is as follows:


												Weighted
												Average
												Remaining	Weighted			Weighted
											Options	Contractual	Average		Options	Average
Range of Exercise Prices:	Options Outstanding		Weighted Average Remaining Contractual Term		Weighted Average Exercise Price		Options Exercisable		Weighted Average Exercise Price		Outstanding	Term	Exercise Price		Exercisable	Exercise Price
$0.01-$1.00		2,670,000		5.87	$	0.34		2,670,000	$	0.34
$1.01-$1.96		94,000		0.26	$	1.84		94,000	$	1.84
$0.01‑$0.49											1,270,000	4.10	$	0.12	1,270,000	$	0.12
$0.50‑$0.99											1,400,000	5.64	$	0.55	1,400,000	$	0.55
Totals		2,764,000						2,764,000			2,670,000				2,670,000

Restricted Stock Awards

On September 1, 2020 we granted a total of 100,000 shares of restricted stock under the 2016 Plan to the board of directors. The stock-based compensation expense of $134,000 for service-based restricted stock was measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. The shares of restricted stock fully vest and cease to be subject to forfeiture ~~on August 31, 2021, or~~ twelve months following the grant date. Each grantee must be serving as a director on the vesting date and must have been continuously serving in such capacity from the grant date through the vesting date for the shares of restricted stock to vest. Prior to the vesting date, the grantee is not permitted to sell, transfer, pledge, assign or otherwise encumber the shares of restricted stock and if the grantee’s service with the Company terminates prior to the vesting date, subject to certain exceptions, the grantee’s restricted stock will be forfeited automatically. Total recognized compensation cost related to the restricted stock award was $44,667 for the nine months ended December 31, 2020. At December 31, 2020 there was $89,333 of unrecognized compensation cost related to these restricted stock awards.

On ~~March 16, 2020~~September 17, 2021, we granted a total of 100,000 shares of restricted stock under the 2016 Plan to the board of directors. The stock-based compensation expense of ~~$111,000~~$175,000 for service-based restricted stock was measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. The shares of restricted stock fully vested and ceased to be subject to forfeiture on September 1, 2020, or approximately six months following the grant date. Each grantee must have been serving as a director on the vesting date and must have been continuously serving in such capacity from the grant date through the vesting date for the shares of restricted stock to vest. Prior to the vesting date, the grantee was not permitted to sell, transfer, pledge, assign or otherwise encumber the shares of restricted stock and if the grantee’s service with the Company had terminated prior to the vesting date, the grantee’s restricted stock would have been forfeited automatically.

Total recognized compensation cost related to the restricted stock ~~award was $101,750~~awards for the ~~nine~~three and six months ended ~~December 31, 2020. There~~September 30, 2021 was no$28,566 and $62,066, respectively. At September 30, 2021 there was $168,767 of unrecognized compensation cost related only to ~~these restricted~~the September 17, 2021 stock ~~awards~~award.

14

Table of Contents

Warrants

On August 25, 2021, we issued warrants to purchase 100,000 shares of our common stock in connection with the Stadco acquisition. The warrants vested in full on the issue date, have a three year term and exercise price of $1.43 per share. The fair value of the warrants was $46,256 and estimated using the Black-Scholes option-pricing model based on the closing stock prices at ~~December 31, 2020.~~the grant date and the weighted average assumptions specific to the grant. Expected volatility of 46.7% was based on the historical volatility of our common stock. The risk-free interest rate of 0.4% was selected based upon yields of three-year U.S. Treasury bond.

NOTE 8 - CONCENTRATION OF CREDIT RISK

We maintain bank account balances, which, at times, may exceed insured limits. We have not experienced any losses with these accounts and believe that we are not exposed to any significant credit risk on cash.

At ~~December 31, 2020,~~September 30, 2021, there were trade accounts receivable balances outstanding from ~~five~~3 customers comprising ~~93%~~74% of the total trade receivables balance. The following table sets forth information as to trade accounts receivable from customers who accounted for more than 10% of ~~the total~~our accounts receivable balance ~~at:~~as of:

	December 31, 2020					March 31, 2020

										September 30, 2021				March 31, 2021
Customer	Dollars		Percent			Dollars		Percent		Amount		Percent		Amount		Percent
A	$	356,228		30	%	$	*	*		$	1,079,264	41	%	$	*	*	%
B	$	243,938		21	%	$	*	*		$	*	*	%	$	399,692	66	%
C	$	193,750		17	%	$	*	*		$	576,640	22	%	$	193,368	32	%
D	$	*		*		$	365,636	37	%	$	290,503	11	%	$	*	*	%
E	$	167,152		14	%	$	254,637	26	%
F	$	*		*		$	123,000	12	%
G	$	123,909		11	%	$	*	*

*less*less than 10% of total

NOTE 9 - OTHER CURRENT ASSETS

	December 31, 2020		March 31, 2020

Other current assets included the following at:					September 30, 2021		March 31, 2021
Payments advanced to suppliers	$	31,268	$	272,070	$	22,377	$	17,010
Prepaid insurance		358,029		250,073		291,141		312,669
Prepaid subscriptions		22,057		14,440		52,961		25,967
Refundable AMT credits		22,748		22,748
Employee advances		--		18,173		26,985		16,526
Deposits						145,979		—
Prepaid taxes						64,194		—
Other		7,922		28,647		8,011		7,265
Total	$	442,024	$	606,151	$	611,648	$	379,437

NOTE 10 - PROPERTY, PLANT AND EQUIPMENT, NET


Property, plant and equipment, net included the following at:	September 30, 2021		March 31, 2021
Land	$	110,113	$	110,113
Building and improvements		3,289,901		3,249,577
Machinery equipment		17,883,604		10,113,670
Furniture, fixtures, auto equipment		1,503,041		627,571
Total property, plant and equipment		22,786,659		14,100,931
Less: accumulated depreciation		(10,480,258)		(10,037,722)
Total property, plant and equipment, net	$	12,306,401	$	4,063,209

15

Table of Contents

NOTE 1011 - ACCRUED EXPENSES

	December 31, 2020		March 31, 2020

Accrued expenses included the following at:					September 30, 2021		March 31, 2021
Accrued compensation					$	994,838	$	496,320
Provision for claims settlement	$	495,000	$	495,000		—		495,000
Accrued compensation		316,490		383,555
Provision for contract losses		110,115		285,480		343,763		164,164
Accrued professional fees		244,703		279,657		333,366		213,213
Accrued project costs		109,062		76,059		436,070		114,611
Other		30,739		34,773		212,856		42,962
Total	$	1,306,109	$	1,554,524	$	2,320,893	$	1,526,270

Accrued compensation includes amounts for executive bonuses, payroll and vacation and holiday pay. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in the provision are recorded in cost of sales. Accrued project costs are estimates for certain project expenses during the reporting period.

NOTE ~~11 -~~12 – DEBT

Total debt included the following as of:	December 31, 2020		March 31, 2020
Berkshire Term Loan at 5.21% interest, due December 2021	$	2,491,835	$	2,564,389
Berkshire SBA PPP loan at 1% interest, due May 2022		1,317,100		--
Finance lease obligations at 8% interest, due January 2022		13,662		22,460

Long-term debt included the following at:					September 30, 2021		March 31, 2021
Stadco Term Loan at 3.79% interest, due August 2028					$	3,958,664	$	—
Ranor Term Loan at 5.21% interest, due December 2021						2,415,964		2,466,408
Revolver loan						865,049		—
SBA PPP loan at 1% interest, due May 2022						—		1,317,100
Finance lease liability						—		45,663
Total debt	$	3,822,597	$	2,586,849	$	7,239,677	$	3,829,171
Less: debt issue costs unamortized	$	16,485	$	20,460	$	117,708	$	12,270
Total debt, net	$	3,806,112	$	2,566,389	$	7,121,969	$	3,816,901
Less: Current portion of long-term debt	$	3,088,553	$	109,829	$	3,790,525	$	2,474,963
Total long-term debt, net	$	717,559	$	2,456,560	$	3,331,444	$	1,341,938

~~Small Business Administration~~Amended and Restated Berkshire Loan Agreement

On August 25, 2021, the Company entered into an amended and restated loan agreement with Berkshire Bank, or the Loan Agreement. Under the Loan Agreement, Berkshire Bank will continue to provide the Ranor Term Loan (as defined below) and the revolving line of credit, or the Revolver Loan. In addition Berkshire Bank provided the Stadco Term Loan (as defined below) in the original amount of $4,000,000. The proceeds of the original Ranor Term Loan of $2,850,000 were previously used to refinance existing mortgage debt of Ranor. The proceeds of the Revolver Loan are used for working capital and general corporate purposes of the Company. The proceeds of the Stadco Term Loan were to be used to support the acquisition of Stadco and refinance existing indebtedness of Stadco. For purposes of the discussion of the Loan Agreement, Ranor and Stadco are referred to together as the “Borrowers.”

Stadco Term Loan

On ~~May 8, 2020,~~August 25, 2021, the Company ~~through its wholly owned subsidiary Ranor, issued a promissory note,~~borrowed $4,000,000 from Berkshire Bank, or the ~~Note, evidencing an unsecured loan~~Stadco Term Loan. Interest on the Stadco Term Loan is due on unpaid balances beginning on August 25, 2021 at a fixed rate per annum equal to the 7 year Federal Home Loan Bank of Boston Classic Advance Rate plus 2.25%. Commencing on September 25, 2021 and on the 25th day of each month thereafter, Stadco shall make monthly payments of principal and interest in the amount of ~~$1,317,100~~$54,390 each, with all outstanding principal and accrued interest due and payable on August 25, 2028. Interest shall be calculated on the basis of actual days elapsed and a 360-day year.

16

Table of Contents

The Company shall pay a late charge in the amount of 5% of each payment due under the Stadco Term Loan (other than the balloon payment due at maturity) which is more than ten days in arrears. In addition, from and after the date on which the Stadco Term Loan becomes, or at Berkshire Bank’s option, could become due and payable (whether accelerated or not), at maturity, upon default or otherwise, interest shall accrue and shall be immediately due and payable at the default rate equal to 5% per annum greater than the interest rate otherwise in effect, but in no event higher than the maximum interest rate permitted by law.

Ranor Term Loan

A term loan was made to Ranor ~~under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, and is administered~~ by ~~the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.~~

Principal and accrued interest are payable monthly in equal installments commencing at a future date in calendar year 2021 and continuing through the maturity date, unless the Note is forgiven as described below. To be available for loan forgiveness, the Note may only be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligations that existed before February 15, 2020. The Note may be prepaid at any time prior to maturity with no prepayment penalties and contains events of default and other conditions customary for a Note of this type. For example, the Note contains events of default relating to, among other things, payment defaults, making materially false and misleading representations to the SBA or Berkshire Bank ~~or breaching the terms of the loan documents. The occurrence of an event of default may result~~ in ~~the repayment of all amounts outstanding, collection of all amounts owing from the Company, or the SBA or Berkshire Bank filing suit and obtaining judgment against the Company and/or Ranor.~~

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in any regulations and guidelines the SBA may adopt. While the Company currently believes that its use of the Note proceeds will meet the conditions for forgiveness under the PPP, no assurance is provided that the Company will obtain forgiveness of the Note in whole or in part.

On June 5, 2020, the PPP was amended to give borrowers more time to spend loan proceeds and still obtain loan forgiveness. The amendments extended the length of the covered period as defined in the CARES Act from eight to twenty-four weeks, while allowing borrowers that received PPP loans before June 5, 2020 to elect to use the original eight-week covered period. In addition, the amendments provide that if the borrower does not apply for forgiveness of a loan within ten months after the last day of the covered period, the PPP loan is no longer deferred and the borrower must begin paying principal and interest. As provided under the amendments, our ~~first payment, if required, would not be due until September 11, 2021.~~

~~Berkshire Term Loan Facility~~

~~On December 21,~~ 2016 ~~TechPrecision, through Ranor, closed on a Loan Agreement, or the Berkshire Loan Agreement, with Berkshire Bank. Pursuant to the Berkshire Loan Agreement, Berkshire Bank made a term loan to Ranor~~ in the amount of $2,850,000, or the Ranor Term ~~Loan,~~Loan. Payments began on January 20, 2017 and will be made ~~available~~in 60 monthly installments of $19,260 each, inclusive of interest at a fixed rate of 5.21% per annum, with all outstanding principal and accrued interest due and payable on the maturity date. A balloon principal payment of approximately $2,400,000 is due on December 20, 2021 under the Term Loan. A prepayment penalty will apply during the loan term but will not apply if a prepayment is made from either casualty loss insurance proceeds or a condemnation award applicable to ~~Ranor~~any collateral or if a ~~revolving line of credit of $1,000,000~~full prepayment is made during the 45-day period immediately preceding the maturity date.

RevolverLoan

In accordance with the amended loan agreement, the maximum amount that can now be borrowed under the Revolver ~~Loan, or together, the Berkshire Loans. The Berkshire Loans are secured by a first lien on all personal and real property of Ranor.~~

On December 23, 2019, TechPrecision, through Ranor, entered into a Third Modification to Loan Agreement, or the Third Modification, and an Amended and Restated Promissory Note with Berkshire Bank. Under the Third Modification, Ranor and Berkshire agreed to increase the maximum principal amount available under the Revolver Loan from $1,000,000 to $3,000,000.loan is $5,000,000. Advances under the Revolver Loan are ~~now~~ subject to a borrowing base equal to the lesser of (a) ~~$3,000,000~~$5,000,000 or (b) the sum of (i)80% of ~~eligible accounts receivable,~~ the net outstanding amount of Base Accounts, plus (ii) the lesser of (x) 25% of Eligible Raw Material Inventory, and (y) $250,000, plus (iii) ~~50%~~80% of the Appraised Value of the Eligible ~~Equipment.~~ Equipment, as such terms are defined in the Loan Agreement.

The ~~loan~~Company agrees to pay to Berkshire Bank, as consideration for Berkshire Bank’s agreement ~~is available for refinancing existing indebtedness and for working capital and general corporate purposes. Additionally, the parties agreed~~ to ~~lower the interest rate on advances made under~~make the Revolver Loan atavailable, a ~~variable rate~~nonrefundable Revolver Loan fee equal to 0.25% per annum (computed on the ~~one-month LIBOR plus 225~~ basis ~~points. The Third Modification contains customary LIBOR replacement provisions.~~

~~On December 18, 2020, TechPrecision, through Ranor, entered into~~of a ~~Fourth Modification to Loan Agreement~~year of 360 days and ~~First Modification~~actual days elapsed) on the difference between the amount of: (a) $5,000,000, and ~~Allonge to Amended and Restated Promissory Note, or~~(b) the Fourth Modification, with Berkshire Bank. The Modification amends and modifies the Berkshire Loan Agreement. The Fourth Modification also amends the Amended and Restated Promissory Note dated December 23, 2019 made by Ranor in favor of Berkshire in the stated principal amount of $3,000,000. Asaverage daily outstanding balance of the Revolver Loan during the quarterly period then ended. All Revolver Loan fees shall be payable quarterly in arrears on the first day of each January, April, July and October after the amendment date ~~of the Fourth Modification, there was approximately $2.5 million in remaining principal outstanding under the Term Loan~~commencing October 1, 2021 and ~~no amounts outstanding under the Revolver Loan.~~

~~Under the Fourth Modification, Ranor and Berkshire agreed to revise the minimum interest rate payable~~ on the Revolver ~~Loan.~~ Maturity Date, or upon acceleration of the Revolver Loan, if earlier.

Under the promissory note for the Revolver Loan, the Company can elect to pay interest at an adjusted LIBOR-based rate or an Adjusted Prime Rate. Under the Fourth Modification, the minimum adjusted LIBOR-based rate is 2.75% and the Adjusted Prime Rate is the greater of (i) the Prime Rate minus 70 basis points or (ii) 2.75%. Interest-only payments on advances made under the Revolver Loan will continue to be payable monthly in arrears. The maturity date of the Revolver Loan ~~was also extended to~~is December 20, 2022. ~~All other material terms of the Berkshire Loan Agreement and the promissory note for the Revolver Loan were unchanged.~~This agreement contains customary LIBOR replacement provisions

~~The Company~~There was $865,049 borrowed ~~$1.0 million under the Revolver Loan on April 3, 2020 and repaid principal of $1.0 million on June 30, 2020. There were no borrowed amounts outstanding~~ under the Revolver Loan at ~~December 31, 2020 and March 31, 2020.~~September 30, 2021. Interest payments ~~on advances~~ made under the Revolver Loan ~~during~~was $1,444 for the ~~nine~~six months ended ~~December 31, 2020 were $6,664 at a weighted average interest rate of 2.67%.~~September 30, 2021. Unused borrowing capacity at ~~December~~September 30, 2021 and March 31, ~~2020~~2021 was ~~$3.0 million.~~

approximately $3.5 and $2.7 million, respectively.

The Ranor Term Loan, the Stadco Term Loan and the Revolver Loan, or together, the Berkshire Loans, may be accelerated upon the occurrence of an event of default as defined in the Berkshire Loan Agreement.

17

Table of Contents

Pursuant to the Berkshire Loan Agreement, ~~contains a covenant whereby~~ the Company ~~is required~~agrees to maintain ~~a debt service coverage~~the ratio ~~or DSCR, of at least 1.2 to 1.0 during the term~~ of the ~~Berkshire Loans. The DSCR is~~Cash Flow (as defined below) of the Company to the Total Debt Service (as defined below) of the Company of not less than 1.20 to 1.00, measured atquarterly on the last day of each fiscal quarter-annual period of the Company on a trailing twelve (12) month basis, commencing with the fiscal quarter ending as of September 30, 2021. Calculations will be based on the audited (year-end) and unaudited (quarterly) consolidated financial statements of the Company. Quarterly tests will be measured based on the Form 10-Q reports within sixty (60) days of the end of each quarter, and annual tests will be measured based on Form 10-K reports within one hundred twenty days (120) after the end of each fiscal annual period. Cash Flow means an amount, without duplication, equal to the sum of net income of the Company plus (i) interest expense, plus (ii) taxes, plus (iii) depreciation and amortization, plus (iv) stock based compensation expense taken by the Company, plus (v) non-cash losses and charges and one time or non-recurring expenses at Berkshire Bank’s discretion, less (vi) the amount of cash distributions, if any, made to stockholders or owners of the Company, less (vii) cash taxes paid by the Company, all as determined in accordance with GAAP. Total Debt Service shall mean an amount, without duplication, equal to the sum of (i) all amounts of cash interest paid on liabilities, obligations and reserves of the Company paid by the Company, (ii) all amounts paid by the Company in connection with current maturities of long-term debt and preferred dividends, and (iii) all payments on account of capitalized leases, all as determined in accordance with GAAP.

The Company agrees to cause its Balance Sheet Leverage to be less than or equal 2.50 to 1.00. Compliance with the foregoing shall be tested quarterly, as of the last day of each fiscal quarter of the ~~Company.~~ Company, commencing with the fiscal quarter ending September 30, 2021. Balance Sheet Leverage means, at any date of determination, the ratio of Borrowers’ (a) Total Liabilities, less Subordinated Debt, to (b) Net Worth, plus Subordinated Debt.

The Borrowers agree to maintain a Loan to Value Ratio of not greater than 0.75 to 1.00. Loan to Value Ratio means the ratio of (a) the sum of the outstanding balance of the Ranor Term Loan and the Stadco Term Loan, to (b) the fair market value of the Property, as determined by an appraisal obtained from time to time by Berkshire Bank, but not more frequently than one time during each 365 day period (provided that Berkshire Bank may obtain an appraisal at any time after either the Ranor Term Loan or the Stadco Term Loan has been accelerated), which appraisals shall be at the expense of the Borrowers.

The Borrowers agree that their combined annual capital expenditures shall not exceed $1,500,000. Compliance shall be tested annually, commencing with the fiscal year ending March 31, 2022.

The Company was in compliance with all of the financial covenants at ~~December 31, 2020~~September 30, 2021 and March 31, ~~2020.~~2021.

Unamortized debt issue costs at September 30, 2021 and March 31, 2021 were $117,708 and $26,272, respectively.

~~The Berkshire Loan Agreement also contains covenants to cause its balance sheet leverage to be less than or equal to 2.50 to 1.00 for each fiscal year end,~~Collateral securing the above obligations comprises all personal and ~~require Ranor to maintain a loan-to-value ratio~~real property of ~~not greater than 0.75 to 1.00, to be measured by appraisal not more frequently than one time during each 365-day period.~~

~~Finance Lease~~

~~See Note 12 for information regarding our obligations under~~ the ~~finance lease.~~

~~Fair Value Measurements~~

~~We account for fair value measurements in accordance with ASC Topic 820,~~ ~~Fair Value Measurement,~~ ~~which defines fair value~~Company, including cash, accounts receivable, inventories, equipment, and ~~establishes a framework to measure fair value and the related disclosures about fair value. The~~financial assets.The carrying value of short and long-term borrowings approximates their fair value at December 31, 2020 and March 31, 2020. The fair value of the long-term debt was calculated based on interest rates available for debt with terms and maturities similar to the Company's existing debt arrangements.value. The Company’s short-term and long-term debt ~~with Berkshire bank~~ is all privately held with no public market for ~~the~~this debt and is considered to be Level 3 under the fair value hierarchy.

Small Business Administration Loan

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, issued a promissory note, or the PPP Note, evidencing an unsecured loan in the amount of $1,317,100 made to Ranor under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act and is administered by the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.

Principal and accrued interest were set to be payable monthly in equal installments commencing in September 2021 and continuing through the maturity date, unless the PPP Note was forgiven as described below.

18

Table of Contents

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities.

On June 5, 2020, the PPP was amended to give borrowers more time to spend loan proceeds and still obtain loan forgiveness. The amendments extended the length of the covered period as defined in the CARES Act from eight to twenty-four weeks, while allowing borrowers that received PPP loans before June 5, 2020 to elect to use the original eight-week covered period.

The Company applied for loan forgiveness with the SBA under the Paycheck Protection Program on March 26, 2021. On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal and interest in the amount of $1,317,100 and $13,207, respectively, for forgiveness of the Company’s PPP loan. The funds credited to the bank paid this loan off in full. Loan forgiveness is recorded as a gain under other income and expense in the condensed consolidated statement of operations.

NOTE 1213 – LEASES

After we settled certain default amounts, Stadco became party to an amended building and property operating lease and recorded a right of use asset and liability of $6.6 million. Monthly base rent for the property will be $78,233 per month, with a 20% discount through November 30, 2022. The term of the lease will expire on June 30, 2030. The lease contains customary default provisions allowing the Landlord to terminate the lease if the lessee fails to remedy a breach of its obligations under the lease within the time period specified in the lease, or upon certain events of bankruptcy or seizure or attachment of the lessee’s assets or interest in the lease. The lease also contains other customary provisions for real property leases of this type.

Leases that are economically similar to the purchase of an asset are classified as finance leases. The leased, or right-of-use assets in finance lease arrangements are reported in net property, plant and equipment on our condensed consolidated balance sheet. Right-of-use assets and liabilities on our condensed consolidated balance sheet at December 31, 2020 were:

Finance lease: December 31, 2020
Property, plant and equipment $ 54,376
Accumulated depreciation 43,501
Net property, plant and equipment $ 10,875
Current portion of long-term debt $ 12,569
Long-term debt $ 1,093
Total finance lease liabilities $ 13,662

In December 2019, we signed a one-year operating lease for office space which expired in December 2020 and was amortized on a straight line basis. Since the expiration ~~of the term of the lease,~~date, we have continued to lease this office space on a month-to-month basis.

The following table lists our right-of-use assets and lease liabilities in our condensed consolidated balance sheet at:


	September 30, 2021		March 31, 2021
Right of use asset – operating lease	$	6,655,724	$	—
Right of use asset – finance leases		98,704		45,663
Amortization		(73,268)		—
Right of use asset, net	$	6,681,160	$	45,663
Lease liability – operating lease	$	6,590,614	$	—
Lease liability – finance leases	$	108,205	$	45,663
Total lease liability	$	6,698,819	$	45,663

19

Table of Contents

Other supplemental information regarding our leases are contained in the following tables:

Components of lease expense for the period ended:	December 31, 2020

Components of lease expense for the six months ended:			September 30, 2021		September 30, 2020
Operating lease amortization	$	2,878	$	68,702	$	1,883
Finance lease amortization	$	8,156	$	4,566	$	5,438
Finance lease interest	$	1,102	$	1,212	$	793

~~Weighted average lease term and discount rate at:~~	~~December 31, 2020~~
~~Finance lease term (years)~~		~~1.25~~
~~Finance lease rate~~		8	%


Weighted average lease term and discount rate at:	September 30, 2021		September 30, 2020
Lease term (years) – operating lease	8.75		—
Lease term (years) – finance leases	2.82		1.75
Lease rate – operating lease	4.5	%	—
Lease rate – finance leases	3.9	%	8.0	%

Supplemental cash flow information related to leases for the period ended:	December 31, 2020

Supplemental cash flow information related to leases for the six months ended:			September 30, 2021		September 30, 2020
Cash used in operating activities	$	2,878	$	66,023	$	1,883
Cash used in financing activities	$	8,798	$	475,440	$	5,807

Maturities of lease liabilities at September 30, 2021 for the next five years and thereafter:


2022	$	818,817
2023		925,766
2024		951,171
2025		948,701
2026		943,752
Thereafter		3,520,506
Total lease payments	$	8,108,713
Less: imputed interest		1,409,894
Total	$	6,698,819

NOTE 1314 - COMMITMENTS

Employment Agreements

We have employment agreements with each of our executive officers. Such agreements provide for minimum salary levels, adjusted annually, and incentive bonuses that are payable if specified company goals are attained. The aggregate commitment at September 30, 2021 for future executive salaries and bonus was approximately $1.2 million. The aggregate commitment at September 30, 2021 for accrued payroll, vacation and holiday pay was approximately $0.8 million for the remainder of our employees.

Retirement Benefits

Ranor has a defined contribution and savings plan that covers substantially all Ranor employees who have completed 90 days of service. Ranor retains the option to match employee contributions. The Company contributed ~~$21,897~~$43,240 and ~~$64,167~~$42,270 for the three and ~~nine~~six months ended ~~December 31, 2020.~~September 30, 2021 and 2020, respectively.

20

Table of Contents

NOTE 15 – ACCOUNTING STANDARDS UPDATE

~~Provision~~New Accounting Standards Recently Adopted

In December 2019, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for ~~claims settlement~~Income Taxes

~~On March 16, 2020, the Company reached an agreement~~, expected to ~~settle all outstanding claims for $495,000~~reduce cost and complexity related to the accounting for income taxes. This ASU removes specific exceptions to the general principles in Topic 740 under U.S. GAAP and removes the limitation on the tax benefit recognized on pre-tax losses in interim periods. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company adopted ASU 2019-12 on April 1, 2021 and the amendments in this update did not have a ~~civil action brought by former employees~~significant impact on our financial statements and disclosures.

Issued Standards Not Yet Adopted

In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805), Accounting for ~~past wages claimed under~~Contract Assets and Contract Liabilities from Contracts with Customers, which requires contract assets and contract liabilities acquired in a ~~paid time-off program. The claim is~~business combination to be ~~paid within sixty days following Court approval of~~recognized and measured by the ~~settlement. Such approval has not yet occurred.~~

~~NOTE 14 – SUBSEQUENT EVENTS~~

~~Securities Purchase Agreement~~

~~On October 16, 2020,~~acquirer on the ~~Company entered into a stock purchase agreement, or the SPA,~~acquisition date in accordance with Stadco New Acquisition, LLC, a wholly owned subsidiary of the Company, or the Acquisition Sub, Stadco, Stadco Acquisition, LLC, or the Target, and each stockholder of Target. The SPA provides for the Company, through Acquisition Sub, to acquire all of the issued and outstanding capital stock of StadcoASC 606, Revenue from ~~Target. Stadco, the operating subsidiary of Target, is a California corporation~~Contracts with Customers. Generally, this new guidance will result in the ~~business of manufacturing high-precision parts, assemblies~~acquirer recognizing contract assets and ~~tooling~~contract liabilities at the same amounts recorded by the acquiree. The amendments in this update are effective for aerospace, defense, research and commercial customers. As consideration for the acquisition of all of Target’s common stock, the Company, on behalf of Acquisition Sub, will issue 1,000,000 shares of the Company’s common stock to Target.fiscal years beginning after December 15, 2022, including interim periods within these fiscal years. The Company ~~Stadco~~is currently evaluating the impact that this new guidance may have on our financial statements and ~~Target are also working, through negotiation with creditors~~disclosures.

In May 2021, the FASB issued ASU 2021-04, Issuer’s Accounting for Certain Modifications or Exchanges of ~~Stadco~~Freestanding Equity-Classified Written Call Options Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options. The FASB issued this update to clarify and ~~Target, to substantially~~ reduce ~~the approximately $14 million~~diversity in issuer’s accounting for modifications or exchanges of ~~Stadco liabilities~~freestanding equity-classified written call options (for example, warrants) that ~~would otherwise be added~~remain equity classified after modification or exchange. The amendments that relate to the ~~consolidated balance~~recognition and measurement of EPS for certain modifications or exchanges of freestanding equity-classified written call options affect entities that present EPS in accordance with the ~~combined company after closing of the acquisition. Reaching agreements with these creditors to the satisfaction of the~~guidance in Topic 260, Earnings Per Share. The Company is ~~required for~~currently evaluating the ~~closing of the deal to occur. The Company expects~~impact that ~~a percentage of these liabilities will be satisfied in part or full through the issuance of additional shares of the Company’s common stock.~~this new guidance may have on our financial statements and disclosures.

The SPA contains customary representations and warranties of Stadco, Target, the Company and Acquisition Sub, and Stadco and Target have agreed to customary covenants relating to the conduct of their business during the interim period between the execution of the SPA and the closing of the acquisition. The consummation of the acquisition and the related transactions contemplated by the SPA is subject to certain customary conditions.

On February 2, 2021, the Company entered into an amendment effective as of December 15, 2020, to the previously disclosed stock purchase agreement providing for the Acquisition with Acquisition Sub, Stadco, Target and each stockholder of Target. Under the terms of SPA, if the Acquisition was not closed by December 31, 2020, either the Company or Stadco could have terminated the SPA. The Amendment effected a change to this provision by extending until February 28, 2021 the date after which the parties may terminate if the Acquisition has not closed. The Amendment also effected certain other minor changes to the SPA.

~~Loan Purchase and Sale Agreement~~

On January 29, 2021, in connection with securities purchase agreement described above, Acquisition Sub entered into a Loan Purchase and Sale Agreement, effective January 26, 2021, with Sunflower Bank, N.A., and agreed to by Stadco, Target, and Stadco Mexico, Inc. Under the terms of the Loan Purchase Agreement, Acquisition Sub agreed to purchase certain indebtedness obligations of Stadco consisting of long-term indebtedness and revolving credit line indebtedness owed to Sunflower Bank. The current amount outstanding under these indebtedness obligations is approximately $9.8 million. In exchange, Acquisition Sub agreed to pay $2 million less than the aggregate amount of the indebtedness that is then outstanding on the date of the closing of the transactions contemplated under the Loan Purchase Agreement. The closing of the indebtedness purchase is subject to the closing of the acquisition contemplated under the SPA and will take place on or about February 15, 2021, with an optional grace period of up to an additional 15 days. In connection with the closing, Acquisition Sub will also guaranty repayment by Stadco to Sunflower Bank of any of the original approximately $1.5 million in principal indebtedness under Stadco’s Paycheck Protection Program Loan that is not forgiven under the terms of the Coronavirus Aid, Relief, and Economic Security Act. The Loan Purchase Agreement contains customary representations and warranties of each party, as well as mutual indemnification provisions.

~~Item 2.~~

NOTE 16 – SUBSEQUENT EVENT

On October 5, 2021, the Company issued 20,000 shares of common stock to a third-party consultant as a payment for a finder’s fee in connection with the acquisition of Stadco. The estimated fair value of the award is $35,000 and was measured on the date of grant based on the number of shares issued and the quoted market price of the Company’s common stock.

21

Table of Contents

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statement Regarding Forward Looking Disclosure

The following discussion of the results of our operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to risks and uncertainties arising from:

●our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;

●our ability to balance the composition of our revenues and effectively control operating expenses;

●external factors, including the COVID-19 pandemic, that may be outside of our control;

●the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto;

●the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;

●our ability to receive contract awards through competitive bidding processes;

●our ability to maintain standards to enable us to manufacture products to exacting specifications;

●our ability to enter new markets for our services;

●our reliance on a small number of customers for a significant percentage of our business;

●competitive pressures in the markets we serve;

●changes in the availability or cost of raw materials and energy for our production facilities;

●operating in a single geographic location;

●restrictions in our ability to operate our business due to our outstanding indebtedness;

●government regulations and requirements;

●pricing and business development difficulties;

●changes in government spending on national defense;

●our ability to make acquisitions and successfully integrate those acquisitions with our business;

●general industry and market conditions and growth rates;

22

Table of Contents

	·●	~~our reliance on individual purchase orders, rather than long-term contracts,~~failure to ~~generate revenue;~~
	·	~~our ability to balance~~successfully integrate and realize the ~~composition of our revenues and effectively control operating expenses;~~
	·	~~external factors, including the COVID-19 pandemic, that may be outside of our control;~~
	·	~~the impacts~~expected benefits of the ~~COVID-19 pandemic and government-imposed lockdowns in response thereto;~~
	·	~~the availability of appropriate financing facilities impacting~~Stadco acquisition could have an adverse effect on our ~~operations,~~business, financial condition ~~and/or liquidity;~~
	·	~~our ability to receive contract awards through competitive bidding processes;~~
	·	~~our ability to maintain standards to enable us to manufacture products to exacting specifications;~~
	·	~~our ability to enter new markets for our services;~~
	·	~~our reliance on a small number~~and results of ~~customers for a significant percentage of our business;~~
	·	~~competitive pressures in the markets we serve;~~
	·	~~changes in the availability or cost of raw materials~~operations, and ~~energy for our production facilities;~~
	·	~~operating in a single geographic location;~~
	·	~~restrictions in our ability to operate our business due to our outstanding indebtedness;~~
	·	~~government regulations and requirements;~~
	·	~~pricing and business development difficulties;~~
	·	~~changes in government spending on national defense;~~
	·	~~our ability to make acquisitions and successfully integrate those acquisitions with our business;~~
	·	~~general industry and market conditions and growth rates;~~
	·	~~general economic conditions;~~
	·	~~the risk that the proposed acquisition of Stadco may not be completed in a timely manner or at all, which~~ may adversely affect the Company’s ~~business and the price of Company’s~~ common ~~stock;~~stock price;

●risks related to diverting management’s attention from the Company’s ongoing business operations;

●unexpected costs, charges or expenses resulting from the acquisition of Stadco; and

	·●	the failure of either party to satisfy any of the conditions to the consummation of the proposed acquisition of Stadco and uncertainties as to the timing of the consummation of the proposed acquisition;
	·	~~the occurrence of any event, change or other circumstance that could give rise to the termination of the securities purchase agreement governing the acquisition of Stadco;~~
	·	~~the effect of the announcement or pendency of the proposed acquisition of Stadco on the Company’s business relationships, operating results and business generally;~~
	·	~~risks related to diverting management’s attention from the Company’s ongoing business operations;~~
	·	~~unexpected costs, charges or expenses resulting from the proposed acquisition of Stadco; and~~
	·	those risks discussed in “~~Item~~“Item 1A. Risk ~~Factors~~”Factors” and elsewhere in our ~~2020~~ Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

Overview

Contract Manufacturing

WeThrough our Ranor and Stadco subsidiaries, we offer a full range of services required to transform raw materials into precision finished products. Our manufacturing capabilities include: fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, blasting and painting) and machining operations including CNC (computer numerical controlled) horizontal and vertical milling centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), quality control (inspection and testing), materials procurement, production control (scheduling, project management and expediting) and final assembly.

All manufacturing is done in accordance with our written quality assurance program, which meets specific national and international codes, standards, and specifications. ~~Ranor holds several certificates of authorization issued by the American Society of Mechanical Engineers and the National Board of Boiler and Pressure Vessel Inspectors.~~ The standards used are specific to the customers’ needs, and our manufacturing operations are conducted in accordance with these standards.

Because our revenues are derived from the sale of goods manufactured pursuant to ~~a contract,~~contracts, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors. Our business is dependent in part on the continuation of governmental programs ~~which~~that require our services and products.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition and our ability to price our services competitively. Although some of our contracts contemplate the manufacture of one or a limited number of units, we continue to seek more long-term projects with predictable cost structures.

On August 25, 2021, the Company completed its previously announced acquisition of Stadco, a company in the business of manufacturing high-precision parts, assemblies and tooling for aerospace, defense, research and commercial customers. We believe that the Stadco operation fits our primary defense focus and brings a complementary customer list for our defense and industrial markets.

23

Table of Contents

Financial Results

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. Generally, our projects are made up of ~~short-term~~ contracts with a production timeline that can range from three to as much as thirty-six months. Units manufactured under the majority of our customer contracts are delivered on time and with a positive gross margin. Our results of operations for any specific period are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. A delay in deliveries or cancellations of orders could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

If revenue for a particular quarter is below our expectations, we may not be able to proportionally reduce operating expenses for that quarter. Therefore, a revenue shortfall would have a disproportionate effect on our operating results for that quarter. We have reported operating losses in four of the last seven quarters. In Fiscal 2020 we reported a loss from operations of $0.1 million, due primarily to an increase in cost of sales for losses on certain customer projects. Until we complete and deliver the final units from these projects, they will continue to dampen gross margin in future quarterly periods.

For the ~~nine~~three months ended ~~December 31, 2020, our~~September 30, 2021, we recorded net sales and net loss of $4.8 million and $0.2 million, compared with net sales of $4.7 million and net income of $0.3 million, for the three months ended September 30, 2020. For the six months ended September 30, 2021, we recorded net sales and net income ~~were $11.6~~of $8.2 million and ~~$0.1~~$1.2 million, ~~respectively,~~ compared with net sales of ~~$11.1~~$8.0 million and net ~~loss~~income of ~~$0.4~~$0.2 million, for the ~~nine~~six months ended ~~December 31, 2019.~~September 30, 2020. Our ~~gross margin~~financial statements for the ~~nine~~three and six months ended ~~December 31, 2020 and 2019 was 21.9% and 16.6%, respectively. We used $0.3 million of cash in operations for~~September 30, 2021 include the nine months ended December 31, 2020 and had a cash balance of $1.3 million at December 31, 2020. Our sales order backlog at December 31, 2020 and March 31, 2020 was approximately $18.4 million and $16.8 million, respectively.

~~Acquisition of Stadco~~

We recently announced an agreement to purchase a company that manufactures precision parts for the defense and aerospace industries. Incremental costs incurred for due diligence as a result of this agreement could impact earnings in future quarterly periods. Becauseresults of the ~~size of this acquisition target relative to our business, following closing, we expect to report that our results of operations, cash flows and financial condition will differ materially~~Stadco operation from ~~those reported to date. The acquisition agreement is subject to certain conditions, and may or may not be completed unless all~~August 26, 2021 through September 30, 2021.

On May 12, 2021, as authorized by Section 1106 of the ~~conditions set forth~~Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the Small Business Administration, or the SBA, remitted to Berkshire Bank, the lender of record, a payment of principal and interest in the ~~agreement are completed. Failure to successfully integrate~~amount of $1,317,100 and realize the expected benefits of such acquisitions or to implement our acquisition strategy, including successfully integrating acquired businesses, could have an adverse effect on our business, financial condition and results of operations.

~~COVID-19~~

At the end of March 2020, the outbreak of coronavirus (COVID-19) had spread worldwide as a pandemic. The full extent of the outbreak, related business and travel restrictions and changes to social behavior intended to reduce its spread remain uncertain and subject to change as the health crisis continues to evolve in the U.S. and abroad. The directives imposed by federal, state and local governments did not impair our ability to maintain operations during the first nine months of fiscal 2021 as the Company was designated an “Essential Service.” The pandemic has nevertheless negatively affected certain$13,207, respectively, for forgiveness of the Company’s ~~customers, suppliers and labor force, and with~~Paycheck Protection Program loan, or PPP loan. Funds credited to the ~~changing conditions~~bank paid this loan off in full. Loan forgiveness is recorded as a ~~result of the COVID-19 outbreak, the impact on our operations and financial results for the remainder of calendar year 2021 remains uncertain.~~

~~We and our customers have been designated essential services~~ as national critical infrastructure companies by the U.S. Department of Homeland Security. Additionally, we believe that the long term outlook for the defense industry remains positive as we continue to see meaningful opportunities in our defense sector, primarilygain in the ~~nuclear submarine business for the next twelve months and beyond.~~condensed consolidated statement of operations.

Critical Accounting ~~Policies~~

Estimates

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to revenue recognition, inventories, recovery of long-lived assets, income taxes and the valuation of equity transactions. These estimates and assumptions require ~~management's~~management’s most difficult, subjective or complex judgments. Actual results may ~~differ~~vary under different assumptions or conditions.

We consider the principles and estimates applied for revenue recognition to be one of the most critical accounting estimates that we make. Our revenue can fluctuate from quarter-to-quarter as we measure revenue recognition over the duration of a project, or at the end of the project. The Company records most of its revenue over time as it completes performance obligations or at a point-in-time, for example, at the delivery date, when control of the promised goods are transferred to the customer. Project volume for revenue recognized at a point-in-time is generally smaller, can fluctuate from period to period, and is difficult to forecast.

We measure progress for performance obligations satisfied over time using input methods, for example, labor hours expended and time elapsed. As a result, assuming a steady flow of project volume and labor hours, we have the ability to deliver a fair and accurate flow of revenue over time. When project volume is higher or lower, we may report higher or lower amounts of revenue for those given quarterly periods.

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the ~~2020~~2021 Annual Report on Form ~~10-K~~. ~~We consider~~10-K. Except for the ~~policies relating to revenue recognition to be a critical accounting policy. There have been~~addition of our Goodwill policy, there were no significant changes to our critical accounting policies during the ~~nine~~six months ended ~~December 31, 2020.~~September 30, 2021.

24

~~Accounting Pronouncements~~Table of Contents

New Accounting Standards

See Note 3,15, Accounting Standards Update, in the Notes to the condensed consolidated financial statements in “Item 1. Financial Statements” for a discussion of recently adopted new accounting ~~guidance and new accounting guidance not yet adopted.~~

guidance.

Key Performance Indicators

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as Non-GAAP financial measures. Please see the section “EBITDA Non-GAAP financial measure” below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

Three Months Ended ~~December 31,~~September 30, 2021 and 2020 ~~and 2019~~

The following table sets forth information from our condensed consolidated statements of operations and comprehensive income (loss) ~~income,~~, in dollars and as a percentage of revenue:


	September 30, 2021				September 30, 2020				Changes
(dollars in thousands)	Amount		Percent		Amount		Percent		Amount		Percent
Net sales	$	4,797	100	%	$	4,714	100	%	$	83	2	%
Cost of sales		3,866	80	%		3,585	76	%		281	8	%
Gross profit		931	20	%		1,129	24	%		(198)	(18)	%
Selling, general and administrative		1,174	24	%		696	15	%		478	69	%
Operating income (loss)		(243)	(5)	%		433	9	%		(676)	(156)	%
Other expense, net		(56)	(1)	%		(51)	(1)	%		(5)	(10)	%
Income (loss) before taxes		(299)	(6)	%		382	8	%		(681)	(178)	%
Income tax provision (benefit)		(79)	(2)	%		111	2	%		(190)	(170)	%
Net income (loss)	$	(220)	(5)	%	$	271	6	%	$	(491)	(181)	%

December 31, 2020 December 31, 2019 Changes
(dollars in thousands) Amount Percent Amount Percent Amount Percent
Net sales $ 3,569 100 % $ 3,667 100 % $ (98 ) (3 )%
Cost of sales 2,864 80 % 3,353 91 % (489 ) (15 )%
Gross profit 705 20 % 314 9 % 391 124 %
Selling, general and administrative 716 20 % 663 18 % 53 8 %
Loss from operations (11 ) - % (349 ) (9 )% 338 97 %
Other expense, net (50 ) (1 )% (69 ) (2 )% 19 28 %
Loss before taxes (61 ) (2 )% (418 ) (11 )% 357 85 %
Income tax benefit (13 ) (1 )% (98 ) (3 )% 85 87 %
Net loss $ (48 ) (1 )% $ (320 ) (8 )% $ 272 85 %

~~Net Sales~~

~~The Company records most of its revenue over time as it completes performance obligations. We~~ ~~measure~~ ~~progress for performance obligations satisfied over time using input methods (e.g., labor hours expended and time elapsed).~~

Net sales were $3.6 million for the three months ended December 31, 2020, or 3% lower when compared to net sales for the three months ended December 31, 2019 of $3.7 million. Net sales in our defense markets decreased by $0.3 million when compared to the three months ended December 31, 2019. However, our defense backlog remains strong as new orders for components continue to flow down from our prime defense contractors. Net sales to other commercial markets increased by $0.2 million when compared to the three months ended December 31, 2019, primarily on new projects for components built for a certain nuclear energy customer. We have experienced repeat business in these markets, but the order flow is uneven and difficult to forecast.

~~Cost of Sales and Gross Margin~~

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Cost of sales for the three months ended December 31, 2020 were $0.5 million lower when compared to the three months ended December 31, 2019, primarily because of the absence of any significant contract losses. The fiscal 2020 third quarter included a higher loss provision for certain customer projects.

As a result, gross profit was $0.7 million for the three months ended December 31, 2020, or $0.4 million higher when compared to the three months ended December 31, 2019. Gross margin was 19.8% for the three months ended December 31, 2020 and 8.6% for the three months ended December 31, 2019.

We continue to solve learning-curve challenges on a limited number of projects in the manufacturing schedule which had an unfavorable financial impact in fiscal 2020. Progress notwithstanding, until we complete and deliver the final units from these projects, they could have an unfavorable impact on gross margin in future quarterly periods.

~~Selling, General and Administrative Expenses~~

Total selling, general and administrative expenses for the three months ended December 31, 2020 increased by $54,172 compared to the three months ended December 31, 2019, due primarily to an increase in outside advisory services, which included expenses for the proposed Stadco acquisition.

~~Other Expense, net~~

Interest expense was lower for the three months ended December 31, 2020 when compared to the three months ended December 31, 2019, and should continue to be lower than the prior year, barring any additional borrowings for working capital purposes under our revolving credit facility, or any new credit facility to meet our changing capital resource needs. Debt issue costs increased as the Company began to amortize costs associated with increasing the borrowing limit under the Revolver loan with Berkshire bank and borrowings under the payroll protection program, or PPP. ~~The following table reflects other income and expense, interest expense and amortization of debt issue costs for the three months ended:~~

December 31, 2020 December 31, 2019 $ Change % Change
Other (expense) income, net $ (219 ) $ 185 $ (404 ) (218 )%
Interest expense $ (36,391 ) $ (58,817 ) $ 22,426 38 %
Amortization of debt issue costs $ (14,014 ) $ (10,511 ) $ (3,503 ) (33 )%

~~Income Taxes~~

~~For the three months ended December 31, 2020 and December 31, 2019, we recorded a tax benefit of $13,369 and $97,734, respectively. The tax benefit was the result of an operating loss.~~

~~Net Loss~~

~~As a result of the foregoing, for the three months ended December 31, 2020, we recorded a net loss of $48,172, compared with a net loss of $319,770 for the three months ended December 31, 2019.~~

~~Nine Months Ended December 31, 2020 and 2019~~

~~The following table sets forth information from our condensed consolidated statements of operations and comprehensive (loss) income, in dollars and as a percentage of revenue:~~

December 31, 2020 December 31, 2019 Changes
(dollars in thousands) Amount Percent Amount Percent Amount Percent
Net sales $ 11,566 100 % $ 11,075 100 % $ 491 4 %
Cost of sales 9,035 78 % 9,238 83 % (203 ) (2 )%
Gross profit 2,531 22 % 1,837 17 % 694 38 %
Selling, general and administrative 2,206 19 % 2,145 19 % 61 3 %
Income (loss) from operations 325 3 % (308 ) (3 )% 633 206 %
Other expense, net (159 ) (1 )% (197 ) (2 )% 38 20 %
Income (loss) before taxes 166 2 % (505 ) (5 )% 671 133 %
Income tax expense (benefit) 60 1 % (115 ) (1 )% 175 152 %
Net income (loss) $ 106 1 % $ (390 ) (4 )% $ 496 127 %

Net Sales

~~The Company records most of its revenue over time as it completes performance obligations. We~~ ~~measure~~ ~~progress for performance obligations satisfied over time using input methods (e.g., labor hours expended and time elapsed).~~

Changes in net sales generally reflect a different product mix and project volume when comparing the current and prior ~~year~~ periods. Net sales were ~~4% higher~~$4.8 million for the ~~nine~~three months ended ~~December 31, 2020~~September 30, 2021, or 2% higher when compared to net sales for the ~~nine~~three months ended ~~December 31, 2019. For the nine months ended December 31, 2020, net sales in our defense markets decreased by $0.4 million when compared to the nine months ended December 31, 2019. However, our~~September 30, 2020.

Our defense backlog remains strong as new orders for components continue to flow down from ~~our~~ prime defense ~~contractors. Net~~contractors, including in connection with the U.S. Navy submarine programs. We saw a near dollar-for-dollar offset change between defense and precision industrial sales ~~to other commercial markets increased by $0.9 million~~ when compared to the ~~nine~~same quarter in fiscal 2021. For the three months ended ~~December 31, 2019 on projects completed~~September 30, 2021, net sales to our defense markets increased by $1.2 million or 37% when compared to the three months ended September 30, 2020. The primary reason for ~~customers~~the increase were new defense sales recorded for the first time by our Stadco subsidiary over the last 36 days of the quarter. With our recent acquisition of Stadco now complete, we expect to report higher revenues in future periods.

Net sales to industrial markets decreased by $1.1 million, or 73%, when compared to the ~~nuclear energy and medical markets.~~three months September 30, 2020, due to lower project activity as the Company replenishes its industrial market backlog following a period of above normal revenue for the last three quarters of fiscal 2021. We have ~~experienced~~ repeat business in this sector, but the order flow can be uneven and difficult to forecast.

25

Table of Contents

For the three months ended September 30, 2021, revenue recognized over time and at a point in time was $3.8 and $1.0 million, respectively, compared to revenue recognized over time and at a point in time of $3.1 and $1.6 million, respectively, for the three months ended September 30, 2020.

Cost of Sales and Gross Margin

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the ~~nine~~three months ended ~~December 31, 2020 were $0.2~~September 30, 2021 was $3.9 million, or 8% higher when compared to the three months ended September 30, 2020. Gross margin was 19.4% for the three months ended September 30, 2021 and 24.0% for the three months ended September 30, 2020. Gross profit was $0.9 million for the three months ended September 30, 2021, or 18% lower, when compared to the ~~nine~~three months ended ~~December 31, 2019,~~September 30, 2020, primarily on the ~~absence~~result of ~~any significant contract losses. The fiscal 2020 nine~~higher labor and overhead costs which more than offset lower material costs. These higher costs dampened our margin during the final month ~~period was marked by~~of the quarter when we included our new ~~project startup activities and higher provisions for contract losses.~~

~~Gross profit was $2.5 million~~Stadco operation for the ~~nine months ended December 31, 2020, or 38% higher when compared to~~first time. We anticipate that the ~~nine months ended December 31, 2019. Gross margin was 21.9% for the nine months ended December 31, 2020 and 16.6% for the nine months ended December 31, 2019.~~

inclusion of Stadco’s operations in future periods will result in increased cost of sales in future periods.

Selling, General and Administrative Expenses

Total selling, general and administrative expenses for the ~~nine~~three months ended ~~December 31, 2020~~September 30, 2021 increased by ~~$60,684 as~~69% or $0.5 million. The increase was primarily due to an increase in compensation, ~~and~~insurance costs, office costs, ~~more than offset a decrease~~and outside advisory fees in ~~travel expenses when compared to~~connection with the ~~nine months ended December 31, 2019.~~

Stadco acquisition.

Other Expense, net

The following table reflects interest expense, amortization of debt issue costs and other income, net for the three months ended:


	September 30, 2021		September 30, 2020		$ Change		% Change
Other income, net	$	1,001	$	804	$	197	25	%
Interest expense	$	(48,341)	$	(35,975)	$	(12,366)	(34)	%
Amortization of debt issue costs	$	(8,553)	$	(15,607)	$	7,054	45	%

Interest expense was ~~lower~~higher for the ~~nine~~three months ended ~~December 31, 2020 when compared to~~September 30, 2021. The increase in interest expense for the ~~nine~~three months ended ~~December 31, 2019, and should continue~~September 30, 2021 was due primarily to ~~be lower than the prior year, barring any additional borrowings~~$15,138 for working capital purposes under our revolving credit facility, or any new credit facility to meet our changing capital resource needs. Debt issue costs increased as we began to amortize costs associated with amendments to the existing Berkshire loan agreement bank and new borrowingsinterest under the ~~payroll protection program, or PPP.~~

~~Other income for~~new Berkshire term loan, net of capitalized interest booked in the ~~nine months ended December 31, 2019 included proceeds from the sale of machinery and equipment of $16,000. The following table reflects other income, interest expense and amortization~~same period. Amortization of debt issue costs for the ~~nine~~three months ~~ended:~~ended September 30, 2020 were higher because of higher debt issue costs incurred for the third Berkshire loan modification. We expect to record higher interest expense in the future due to new borrowings under our new Berkshire revolver and term loans.

December 31, 2020 December 31, 2019 $ Change % Change
Other income, net $ 1,237 $ 21,063 $ (19,826 ) (94 )%
Interest expense $ (114,786 ) $ (187,167 ) $ 72,381 39 %
Amortization of debt issue costs $ (45,099 ) $ (31,280 ) $ (13,819 ) (44 )%

Income Taxes

For the ~~nine~~three months ended ~~December 31,~~September 30, 2021 we recorded a tax benefit of $78,642, a result of a pre-tax loss in our second quarter. For the three months ended September 30, 2020 we recorded tax expense of ~~$60,573 and a tax benefit of $115,092 for the nine months ended December 31, 2019. The tax benefit for the nine months ended December 31, 2019 was the result of an operating loss.~~

The valuation allowance on deferred tax assets at December 31, 2020 was approximately $1.7 million. We believe that it is more likely than not that the benefit from certain state and foreign NOL carryforwards and other deferred tax assets will not be realized. In recognition of this risk, we continue to provide a valuation allowance on these items. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

$111,302.

Net Income (Loss)

As a result of the foregoing, for the ~~nine~~three months ended ~~December 31,~~September 30, 2021, we recorded a net loss of $220,413 compared to net income of $270,764 for the three months ended September 30, 2020.

26

Table of Contents

Six Months Ended September 30, 2021 and 2020

The following table sets forth information from our condensed consolidated statements of operations and comprehensive income (loss), in dollars and as a percentage of revenue:


	September 30, 2021				September 30, 2020				Changes
(dollars in thousands)	Amount		Percent		Amount		Percent		Amount		Percent
Net sales	$	8,209	100	%	$	7,996	100	%	$	213	3	%
Cost of sales		6,446	78	%		6,170	77	%		276	4	%
Gross profit		1,763	22	%		1,826	23	%		(63)	(3)	%
Selling, general and administrative		1,906	23	%		1,489	19	%		417	28	%
Operating income (loss)		(143)	(1)	%		337	4	%		(480)	(142)	%
Other expense, net		(75)	(1)	%		(108)	(1)	%		33	31	%
PPP loan forgiveness		1,317	16	%		—	—	%		1,317	nm	%
Income before taxes		1,099	13	%		229	3	%		870	380	%
Income tax provision (benefit)		(52)	(1)	%		74	1	%		(126)	(170)	%
Net income (loss)	$	1,151	14	%	$	155	2	%	$	996	643	%

nm - not meaningful

Net Sales

Changes in net sales generally reflect a different product mix and project volume when comparing the current and prior periods. Net sales were $8.2 million for the six months ended September 30, 2021, or 3% higher when compared to net sales for the six months ended September 30, 2020.

Our defense backlog remains strong as new orders for components continue to flow down from prime defense contractors, including in connection with the U.S. Navy submarine programs and new customer projects from our recent business combination. For the six months ended September 30, 2021, net sales in our defense markets increased by $1.1 million or 17% when compared to the six months ended September 30, 2020. The primary reason for the increase were new defense sales recorded for the first time by our Stadco subsidiary over the last 36 days of the second quarter. With our recent acquisition of Stadco now complete, we expect to report higher revenues in future periods.

Net sales to industrial markets decreased by $0.9 million or 55% when compared to the six months ended September 30, 2020, due to lower project activity as the Company replenishes its industrial market backlog following a period of above normal revenue for the last three quarters of fiscal 2021. We have repeat business in this sector, but the order flow can be uneven and difficult to forecast.

For the six months ended September 30, 2021, revenue recognized over time and at a point in time was $6.9 and $1.3 million, respectively, compared to revenue recognized over time and at a point in time of $6.1 and $1.9 million, respectively, for the six months ended September 30, 2020.

Remaining performance obligations reflect future revenue that will be recorded in subsequent periods as projects in progress are completed. At September 30, 2021, the Company had $17.3 million of remaining performance obligations, of which $13.3 million were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue within the next thirty-six months.

Cost of Sales and Gross Margin

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our manufacturing operations continued to execute effectively with project throughput, notwithstanding higher cost of sales which dampened gross margin for the first six months of fiscal 2022, as we brought our new Stadco operations on-line in the month of September.

27

Table of Contents

Our cost of sales for the six months ended September 30, 2021 was $6.4 million, higher by 4% when compared to the six months ended September 30, 2020, primarily the result of higher labor and overhead costs which more than offset lower material costs. Gross margin was 21.5% for the six months ended September 30, 2021 and 22.8% for the six months ended September 30, 2020. Gross profit was $1.8 million for both six month periods ended September 30, 2021 and 2020.

Selling, General and Administrative Expenses

Total selling, general and administrative expenses for the six months ended September 30, 2021 increased by $0.4 million or 28% when compared with the six months ended September 30, 2020. The increase was primarily due to an increase in compensation, insurance costs, office costs, and outside advisory fees in connection with the Stadco acquisition.

Other Expense, net

The following table reflects interest expense, amortization of debt issue costs and other income, net for the six months ended:


	September 30, 2021		September 30, 2020		$ Change		% Change
Other income, net	$	11,391	$	1,456	$	9,935	nm
Interest expense	$	(68,676)	$	(78,394)	$	9,718	12	%
Amortization of debt issue costs	$	(18,096)	$	(31,086)	$	12,990	42	%

nm – not meaningful

Other income for the six months ended September 30, 2021 includes a return of $10,000 for a retainer fee previously paid for outside advisory fees in connection with a class action settlement in March 2021.

Interest expense for the six months ended September 30, 2021 was lower when compared to the six months ended September 30, 2020. The decrease was due to 1) the reversal of accrued interest for $11,692 for the PPP loan, which was forgiven in May 2021, and 2) lower accruals for interest expense on lower average levels of debt when compared to the same prior year period. These decreases were offset in part by interest expense accrued on new borrowings in connection with the Stadco acquisition in the month of September 2021.

Amortization of debt issue costs for the six months ended September 30, 2021 were lower when compared to the six months ended September 30, 2020. The six months ended September 30, 2020 included higher amortization amounts related to higher debt issue costs related to the third revolver loan modification in 2019.

PPP Loan Forgiveness

On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal in the amount of $1,317,100, for forgiveness of the Company’s PPP loan. The funds credited to the PPP loan paid this loan off in full.

Income Taxes

For the six months ended September 30, 2021 we recorded a tax benefit of $51,882, compared to a tax provision of $73,942 for the six months ended September 30, 2020. The tax benefit is the result of operating pretax losses. The gain from the forgiveness of the Company’s PPP loan is a discrete nontaxable event.

Net Income

As a result of the foregoing, for the six months ended September 30, 2021, we recorded net income of ~~$0.1~~$1.2 million compared ~~with a~~to net ~~loss~~income of ~~$0.4~~$0.2 million for the ~~nine~~six months ~~ended December 31, 2019.~~September 30, 2020.

28

Table of Contents

Liquidity and Capital Resources

At September 30, 2021, we had cash and cash equivalents of $0.3 million and working capital of $4.0 million, a significant decrease when compared to March 31, 2021. We believe our available cash plus cash expected to be provided by operations during fiscal 2022, and borrowing capacity available under the revolver loan will be sufficient to fund expected capital expenditures for our business as it exists today and principal and interest payments under our debt obligations through the 12 months from the issuance date of our financial statements.

On August 25, 2021, we completed the acquisition of Stadco, closed on a private placement financing and closed on a new loan with Berkshire Bank. We raised $3.5 million of cash by selling 3,202,727 shares of common stock at $1.10 per share via a private placement financing, sourced $4.0 million in new debt with Berkshire bank, drew down $0.1 million under the revolver loan, and sourced $1.8 million from available cash. We issued 1.5 million shares of our common stock and warrants to satisfy Stadco’s indebtedness to its shareholders and certain other debt holders and acquired all outstanding shares of Stadco.

In addition, we purchased Stadco’s loan from Sunflower Bank, for a total amount of $7.9 million in cash. Concurrent with the closing of the Stadco acquisition, we entered into an amended and restated loan agreement with Berkshire Bank. Under the amended facility, our term loan in the original principal amount of $2.85 million, of which $2.4 million remains outstanding, will remain, and we will have access to a revolving line of credit of up to $5.0 million, and borrowed $4.0 million under a new term loan with Berkshire bank.

There was $865,049 outstanding under the revolver loan at September 30, 2021. There were no borrowed amounts outstanding under the revolver loan at March 31, 2021. Unused borrowing capacity at September 30, 2021 was approximately $3.5 million. The maturity date of the revolver loan is December 20, 2022.

There is a balloon payment of approximately $2.4 million due on December 20, 2021 under the Ranor term loan with Berkshire Bank. We expect to refinance this debt with the bank before the maturity date. Until then, the Company will continue to pay down principal and make interest payments in the ordinary course.

The table below presents selected liquidity and capital measures at:


					Change
(dollars in thousands)	September 30, 2021		March 31, 2021		Amount
Cash and cash equivalents	$	281	$	2,131	$	(1,850)
Working capital	$	4,008	$	5,202	$	(1,194)
Total debt	$	7,240	$	3,829	$	3,411
Lease liabilities	$	6,698	$	—	$	(6,698)
Total stockholders’ equity	$	16,656	$	9,942	$	6,714

The following table summarizes the primary components of cash flows for the six months ended:


					Change
(dollars in thousands)	September 30, 2021		September 30, 2020		Amount
Cash flows provided by (used in):
Operating activities	$	(1,066)	$	(739)	$	(327)
Investing activities		(8,159)		(355)		(7,804)
Financing activities		7,376		1,255		6,121
Net (decrease) increase in cash and cash equivalents	$	(1,849)	$	161	$	(2,010)

29

Table of Contents

Operating activities

Apart from our loan facilities, our primary sources of cash are from accounts receivable collections, customer advance payments and project progress payments. Our customers make advance payments and progress payments under the terms of each manufacturing contract. Our cash flows can fluctuate significantly from period to period as we mark progress with customer projects and the composition of our receivables collections mix changes between advance payments and customer payments made after shipment of finished goods.

Cash used by operations for the six months ended September 30, 2021 was $1.1 million compared with cash used in operations of $0.7 million for the six months ended September 30, 2020. Cash outlays for the six months ended September 30, 2021 includes a payment of $0.5 million to plaintiffs for a court approved final class action settlement, and $0.7 million of cash used to pay past due rent on the Stadco property and buildings.

The first half of fiscal 2022 was marked by favorable project performance progress and delivery schedules which provided a small amount of cash from operations before the above mentioned payments for $1.2 million in the aggregate. During the first half of fiscal 2021 we encountered some delayed inspections, delayed deliveries, and disrupted supply chain, due to travel restrictions in connection with the COVID-19 pandemic. In addition, we expended more direct labor hours on low margin projects. All of these events resulted in a slower payment flow from customers during the first half of fiscal 2021.

Investing activities

We anticipate that we will spend approximately $0.8 million in new factory machinery and equipment during the remainder of fiscal 2022. Net cash used in investing activities for purchases of property, plant and equipment in the six months ended September 30, 2021 and 2020 was $0.4 million for each period. In addition, we purchased Stadco’s loan from Sunflower Bank, for $7.9 million in cash.

Financing activities

We sourced $3.5 million of cash by selling 3,202,727 shares of common stock at $1.10 per share via a private placement financing and $4.0 million in new debt with Berkshire bank. In addition we drew down $0.9 million under the revolver loan used to fund the acquisition and operating activities in the second quarter of fiscal 2022.

We used $0.5 million of cash to pay off certain lease and debt obligations. We also used $0.5 million of cash to pay private placement closing costs, debt issue costs, repay debt principal and make periodic lease payments.

All of the above activity resulted in a net decrease in cash of $1.8 million for the six months ended September 30, 2021 compared with a net increase in cash of $0.2 million for the six months ended September 30, 2020.

Small Business Administration PPP Loan

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, Inc., issued a promissory note ~~or the Note,~~ evidencing an unsecured PPP loan in the amount of $1,317,100 made to Ranor under the ~~Paycheck Protection Program, or the PPP.~~CARES Act. The PPP ~~was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, and is administered by the U.S. Small Business Administration, or the SBA. The~~ loan to Ranor was made through Berkshire Bank.

The Note provides for an interest rate of 1.00% per year and matures two years after the issuance date. Principal and accrued interest are payable monthly in equal installments commencing on the date that is approximately six months after the date funds are first disbursed on the loan and continuing through the maturity date, unless the Note is forgiven as described below. To be available for loan forgiveness, the Note may only be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligation that existed before February 15, 2020. The Note may be prepaid at any time prior to maturity with no prepayment penalties and contains events of default and other conditions customary for a Note of this type.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of ~~loan~~loans granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities.

30

Table of Contents

The ~~terms of any~~Company applied for loan forgiveness ~~may also be subject to further requirements in any regulations and guidelines~~with the SBA ~~may adopt. While the Company currently believes that its use of the Note proceeds will meet the conditions for forgiveness~~ under the ~~PPP, no assurance is provided that the Company will obtain forgiveness~~Paycheck Protection Program on March 26, 2021. On May 12, 2021, as authorized by Section 1106 of ~~the Note in whole or in part.~~

~~On June 5, 2020, the PPP was amended to give borrowers more time to spend loan proceeds and still obtain loan forgiveness. The amendments extended the length of the covered period as defined in~~ the CARES Act, ~~from eight~~the SBA remitted to ~~twenty-four weeks, while allowing borrowers that received PPP loans before June 5, 2020 to elect to use~~Berkshire Bank, the ~~original eight-week covered period. In addition, the amendments provide that if the borrower does not apply for forgiveness~~lender of record, a ~~loan within ten months after the last day~~payment of ~~the covered period, the PPP loan is no longer deferred and the borrower must begin paying~~ principal and ~~interest. As provided under the amendments, our~~ ~~first payment, if required, would not be due until September 11, 2021.~~

~~Berkshire Term Loan Facility~~

~~On December 21, 2016, TechPrecision, through Ranor, closed on a Loan Agreement with Berkshire Bank. Pursuant to the Berkshire Loan Agreement, Berkshire Bank made a term loan to Ranor~~interest in the amount of ~~$2,850,000,~~$1,317,100 and made available to Ranor a revolving line of credit of $1,000,000 under the Revolver Loan. The debt matures on December 20, 2021, with a balloon payment of approximately $2.4 million due under the terms$13,207, respectively, for forgiveness of the ~~Term Loan with Berkshire bank. We anticipate that we will be able to refinance that debt with Berkshire Bank.~~

On December 23, 2019, TechPrecision, through Ranor, entered into a Third Modification to Loan Agreement, and an Amended and Restated Promissory Note with Berkshire Bank. Under the Third Modification, Ranor and Berkshire agreed to increase the maximum principal amount available under the Revolver Loan from $1,000,000 to $3,000,000.

Company’s PPP loan. The Company borrowed $1.0 million under the Revolver Loan on April 3, 2020 and repaid that principal on June 30, 2020. There were no borrowed amounts outstanding under the Revolver Loan at December 31, 2020 and March 31, 2020. Interest-only payments on advances made under the Revolver Loan during the nine months ended December 31, 2020 totaled $6,664 at a weighted average interest rate of 2.67%.

On December 18, 2020, under the Fourth Modification, Ranor and Berkshire Bank agreed to revise the minimum interest rate payable on the Revolver Loan. Under the Line of Credit Note, the Company can elect to pay interest at an adjusted LIBOR-based rate or an Adjusted Prime Rate. Under the Fourth Modification, the minimum adjusted LIBOR-based rate is 2.75% and the Adjusted Prime Rate is the greater of (i) the Prime Rate minus 70 basis points or (ii) 2.75%. Interest-only payments on advances made under the Revolver Loan will continue to be payable monthly in arrears. The maturity date of the Revolver Loan was also extended to December 20, 2022. All other material terms of the Loan Agreement and Line of Credit Note were unchanged. Unused borrowing capacity at December 31, 2020 was $3.0 million.

At December 31, 2020, we had cash and cash equivalents of $1.3 million and working capital of $4.2 million. We believe our available cash plus cash expected to be provided by operations during fiscal 2021, and borrowing capacity available under the Revolver Loan will be sufficient to fund our operations, capital expenditures and principal and interest payments under our debt obligations through the 12 months from the issuance date of our financial statements. However, following the closing of the acquisition of Stadco, or in connection therewith, we may need to reevaluate our financing needs in light of the significant changes we expectfunds credited to the ~~combined company’s capital resource needs. As~~PPP loan paid this loan off in full. Loan forgiveness is recorded as a ~~result, we may decide to seek new debt and/or equity financing.~~

~~The table below presents selected liquidity~~gain under other income and ~~capital measures at the indicated dates:~~

(dollars in thousands)
December 31,
2020

March 31,
2020

Change
Amount

Cash and cash equivalents $ 1,255 $ 931 $ 324
Working capital $ 4,170 $ 5,595 $ (1,425 )
Total debt $ 3,823 $ 2,587 $ 1,236
Total stockholders’ equity $ 9,694 $ 9,469 $ 225

~~The following table summarizes the primary components of cash flows for the nine months ended:~~

(dollars in thousands)
December 31,
2020

December 31,
2019

Change
Amount

Cash flows provided by (used in):
Operating activities $ (340 ) $ 609 $ (949 )
Investing activities (547 ) (35 ) (512 )
Financing activities 1,211 (642 ) 1,853
Net increase (decrease) in cash $ 324 $ (68 ) $ 392

~~Operating activities~~

Our primary sources of cash are from accounts receivable collections, customer advance payments and project progress payments. Our customers make advance payments and progress payments under the terms of each manufacturing contract. Our cash flows can fluctuate significantly from period to period as the composition of our receivables collections mix changes between advance payments, progress payments and payments made after shipment of finished goods. Cash used in operations for the nine months ended December 31, 2020 was $0.3 million compared with cash provided by operations of $0.6 million for fiscal 2020.

We used cash in operations during the first nine months of fiscal 2021, as accounts receivable and contract assets increased and contract liabilities decreased due to a changing production mix. We have encountered some delayed inspections, deliveries, and disrupted supply chain issues, due to travel restrictions in connection with the COVID-19 pandemic. The future financial impact of the COVID-19 pandemic cannot be reasonably estimated at this time as its impact depends on future developments, which are highly uncertain and cannot be predicted.

~~Investing activities~~

We do not anticipate any additional expenditures for new factory machinery and equipment during the last quarter of fiscal 2021. Net cash used in investing activities for purchases of property, plant and equipmentexpense in the nine months ended December 31, 2020 and 2019 totaled $546,890 and $35,225, respectively. The increase in the nine months ended December 31, 2020 occurred because the Company purchased new robotic equipment during fiscal 2021.

~~Financing activities~~

On May 8, 2020 we borrowed $1.3 million under the CARES Act payroll protection program. On April 3, 2020 we borrowed $1.0 million under our Revolver loan, then paid down $1.0 million in principal on June 30, 2020.

~~For the nine months ended December 31, 2020 and 2019 we made monthly principal payments~~condensed consolidated statement of ~~$81,352 and $610,515 in connection with our term debt and finance lease obligations.~~

All of the above activity resulted in a net increase in cash of $0.3 million for the nine months ended December 31, 2020 compared with a decrease in cash of $0.1 million for the nine months ended December 31, 2019.

operations.

Off-Balance Sheet Arrangements

We do not currently have, and have not had, any off-balance sheet assets, liabilities or arrangements at ~~December 31, 2020.~~

September 30, 2021.

EBITDA Non-GAAP Financial Measure

To complement our condensed consolidated statements of operations and comprehensive income (loss) ~~income~~ and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net income (loss) ~~income~~ is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP.

We define EBITDA as net income (loss) ~~income~~ plus interest, income taxes, depreciation and amortization. Net income was $1.2 million for the six months ended September 30, 2021, as compared to net income of $0.2 million for the six months ended September 30, 2020. EBITDA, a non-GAAP financial measure, was ~~$0.8~~$1.7 million for the ~~nine~~six months ended ~~December 31, 2020,~~September 30, 2021, as compared to ~~$0.3~~$0.7 million for the ~~nine~~six months ended ~~December 31, 2019.~~September 30, 2020. The following table provides a reconciliation of EBITDA to net income (loss) ~~income,~~, the most directly comparable GAAP measure reported in our condensed consolidated financial statements for the following periods:

	Three Months ended December 31,									Nine Months ended December 31,

																		Three Months ended September 30,						Six Months ended September 30,
(dollars in thousands)	2020			2019			Change			2020		2019			Change			2021		2020		Change		2021		2020		Change
Net (loss) income	$	(48	)	$	(320	)	$	272		$	106	$	(390	)	$	496
Income tax (benefit) expense		(13	)		(98	)		85			61		(115	)		176
Net income (loss)																		$	(220)	$	271	$	(491)	$	1,151	$	155	$	996
Income tax expense (benefit)																			(79)		111		(190)		(52)		74		(126)
Interest expense (1)		50			69			(19	)		160		218			(58	)		57		52		5		87		110		(23)
Depreciation and amortization		182			168			14			521		548			(27	)
Depreciation																			333		170		163		516		339		177
EBITDA	$	171		$	(181	)	$	352		$	848	$	261		$	587		$	91	$	604	$	(513)	$	1,702	$	678	$	1,024

(1) Includes amortization of debt issue costs.

~~Item 3.~~

~~Quantitative and Qualitative Disclosure About Market Risk.~~

~~As a smaller reporting company, we have elected not to provide the information required by this Item.~~

~~Item 4.~~

~~Controls and Procedures.~~

Item 3.Quantitative and Qualitative Disclosure About Market Risk.

~~Evaluation of Disclosure Controls and Procedures.~~

~~Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed~~As a smaller reporting company, we have elected not to ~~ensure that~~provide the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

~~As of the end of the period covered~~ by this ~~report, an evaluation was carried out, under the supervision and with the participation~~Item.

31

Table of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2020, our disclosure controls and procedures were effective at a reasonable assurance level.Contents

~~Inherent Limitations Over Internal Controls~~

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

~~Changes in Internal Control over Financial Reporting~~

For the quarter ended December 31, 2020, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

~~PART II. Other Information.~~

~~Item 1A.~~

~~Risk Factors~~

Our ability to complete the acquisition of Stadco is subject to closing conditions, including the receipt of consents and approvals from third parties, which may impose conditions that could adversely affect us or cause the acquisition not to be completed.

Our acquisition of Stadco and its affiliates is subject to a number of closing conditions as specified in the stock purchase agreement entered into with Stadco and its holding company. These include, among others, the entry into arrangements with certain lenders of Stadco and its affiliates and the absence of governmental restraints or prohibitions preventing the consummation of the acquisition. No assurance can be given that the required consents and approvals will be obtained or that the closing conditions will be satisfied in a timely manner or at all. Any delay in completing the acquisition could cause the combined company not to realize, or to be delayed in realizing, some or all of the benefits that we expect to achieve. In addition, we can provide no assurance that these conditions will not result in the abandonment or delay of the acquisition. The occurrence of any of these events could have a material adverse effect on our results of operations, cash flows, financial condition and/or the trading price of our common stock.

~~We may not achieve the intended benefits of our acquisition of Stadco, and the acquisition may disrupt our current plans or operations.~~

We may not be able to successfully integrate Stadco’s business and assets or otherwise realize the expected benefits of the transaction, including anticipated annual operating cost and capital synergies to the extent currently anticipated, or at all. To realize these anticipated benefits, our business and Stadco’s business must be successfully combined, which is subject to our ability to consolidate operations, corporate cultures and systems and our ability to eliminate redundancies and costs. Difficulties in integrating Stadco into our operations may result in the combined company performing differently than expected, in operational challenges or in the failure to realize anticipated synergies and efficiencies in the expected time frame or at all. The integration of the two companies may result in material challenges, including the diversion of management’s attention from ongoing business concerns; retaining key management and other employees; retaining existing business and operational relationships, including customers and other counterparties, and attracting new business and operational relationships; the possibility of faulty assumptions underlying expectations regarding the integration process and associated expenses; consolidating corporate and administrative infrastructures and eliminating duplicative operations; coordinating geographically separate organizations; difficulties in the assimilation of employees and corporate cultures; unanticipated issues in integrating information technology, communications and other systems; as well as unforeseen expenses or delays associated with the acquisition. If we are not successful in integrating Stadco’s business and assets or otherwise fail to realize the expected operating efficiencies, cost savings and other benefits currently anticipated from the Stadco acquisition, our results of operations, cash flows and financial condition may be materially adversely affected.

Whether or not it is completed, the announcement and pendency of the acquisition of Stadco could cause disruptions in our business, which could have an adverse effect on our business and financial results.

Whether or not it is completed, the announcement and pendency of our acquisition of Stadco could cause disruptions in our business: our and Stadco’s current and prospective employees may experience uncertainty about their future roles with the combined company, which might adversely affect the ability to retain key employees; uncertainty regarding the completion of the acquisition may cause customers, suppliers, distributors, vendors, strategic partners or others to delay or defer entering into contracts, make other decisions or seek to change or cancel existing business relationships; and the attention of management may be directed toward the completion of the acquisition. If the acquisition is not completed, we will have incurred significant costs and diverted management resources, for which we will have received little or no benefit.

~~We are expected to incur substantial expenses related to the acquisition of Stadco and its affiliates and the integration of their business with ours.~~

We expect to incur substantial expenses in connection with the integration of our business with Stadco and its affiliates. There are a large number of processes, policies, procedures, operations, technologies and systems that must be integrated, including purchasing, accounting and finance, sales, payroll, pricing, revenue management, marketing and benefits. In addition, our and Stadco’s businesses will continue to maintain a presence in Westminster, Massachusetts and Los Angeles, California, respectively. Some of these costs will be non-recurring expenses related to the acquisition itself, including legal and accounting costs and systems consolidation costs. We may also incur additional costs to attract, motivate or retain management personnel and other key employees. We have incurred and will continue to incur acquisition fees and costs related to formulating integration plans for the combined business, and the execution of these plans may lead to additional unanticipated costs.

~~Our stockholders may not realize a benefit from the acquisition of Stadco commensurate with the ownership dilution they will experience in connection with the transaction.~~

If the combined company is unable to realize the full strategic and financial benefits currently anticipated from the acquisition of Stadco and its affiliates, our stockholders will have experienced substantial dilution of their ownership interests without receiving any commensurate benefit, or only receiving part of the commensurate benefit to the extent the combined company is able to realize only part of the strategic and financial benefits currently anticipated from the acquisition.

~~The market price of our common stock following the acquisition of Stadco may decline as a result of the transaction.~~

~~The market price of our common stock may decline as a result of our acquisition of Stadco and its affiliates for a number of reasons, including if:~~

·

~~investors react negatively to the prospects of the combined company’s business and financial condition following the acquisition;~~

·

~~the effect of the acquisition on the combined company’s business and prospects is not consistent with the expectations of financial or industry analysts; or~~

·

~~the combined company does not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by management and the Company’s investors, or at all.~~

~~Item 6. Exhibits.~~
~~Exhibit Index~~
~~Exhibit No.~~		~~Description~~
2.1*		Stock Purchase Agreement among TechPrecision Corporation, Stadco New Acquisition, LLC, Stadco, Stadco Acquisition, LLC and the stockholders of Stadco, dated as of October 16, 2020 (incorporated by reference to Exhibit 2.1 to our Current Report on Form 8-K, filed with the Commission on October 20, 2020).

~~3.1~~		~~Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to our registration statement on Form SB-2, filed with the Commission on August 28, 2006).~~

~~3.2~~		~~Amended and Restated By-laws of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on February 3, 2014).~~

~~3.3~~		Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on March 3, 2006).

~~3.4~~		Certificate of Amendment to Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.5 to our Quarterly Report on Form 10-Q, filed with the Commission on November 12, 2009).

10.1*		Fourth Modification to Loan Agreement and First Modification and Allonge to Amended and Restated Promissory Note, dated December 18, 2020, between Ranor, Inc. and Berkshire Bank (incorporated by reference to Exhibit 10.1 to our Current Report, filed with the Commission on December 21, 2020)

~~31.1~~		~~Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~

~~31.2~~		~~Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002~~

~~32.1~~		~~Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002~~

~~101~~		The following financial information from this Quarterly Report on Form 10-Q for the three and nine months ended December 31, 2020, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at December 31, 2020 and March 31, 2020; (ii) the Condensed Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended December 31, 2020 and 2019; (iii) the Condensed Consolidated Statements of Stockholders’ Equity for the periods ended December 31, 2020 and 2019; (iv) the Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2020 and 2019; and (v) the Notes to the Condensed Consolidated Financial Statements.

*Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules have been omitted. A copy of any omitted schedule will be furnished supplementally to the Securities and Exchange Commission upon request.

~~SIGNATURES~~

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.~~

		~~TechPrecision Corporation~~

~~February 11, 2021~~	~~By:~~	~~/s/ Thomas Sammons~~
		~~Thomas Sammons~~
		~~Chief Financial Officer~~

Item 4.Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of September 30, 2021, our disclosure controls and procedures were effective at a reasonable assurance level.

Inherent Limitations over Internal Controls

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

For the quarter ended September 30, 2021, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting, except for the acquisition of Stadco. The Company is in the process of evaluating Stadco’s the internal controls over financial reporting and integrating such with its own internal controls over financial reporting.

Table of Contents

PART II. Other Information.

Item 6.Exhibits.

Exhibit Index


Exhibit No.		Description
2.1		Third Amendment to Stock Purchase Agreement, dated as of July 20, 2021, among TechPrecision Corporation, Stadco New Acquisition, LLC, STADCO, Stadco Acquisition, LLC and Douglas A. Paletz, as stockholders’ representative (incorporated herein by reference to Exhibit 2.1 to Form 8-K filed with the Commission on July 26, 2021).*
3.1		Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to our registration statement on Form SB-2, filed with the Commission on August 28, 2006).
3.2		Amended and Restated By-laws of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on February 3, 2014).
3.3		Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on March 3, 2006).
3.4		Certificate of Amendment to Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.5 to our Quarterly Report on Form 10-Q, filed with the Commission on November 12, 2009).
10.1		Amended and Restated Standard Industrial/Commercial Single-Tenant Lease – Net, dated July 1, 2010, between the Landlord and Stadco (incorporated herein by reference to Exhibit 10.1 to our Current Report on Form 8-K filed on August 30, 2021).
10.2		Amendment to the Amended and Restated Standard Industrial/Commercial Single-Tenant Lease – Net, effective as of August 24, 2021, between the Stadco and the Landord (incorporated herein by reference to Exhibit 10.2 to our Current Report on Form 8-K filed with the Commission on August 30, 2021).*
10.3		Amendment to Amended and Restated Loan Purchase and Sale Agreement, dated as of June 28, 2021, between Stadco New Acquisition, LLC, Stadco, Stadco Acquisition LLC and Stadco Mexico, Inc. and Sunflower Bank, N.A. (incorporated herein by reference to Exhibit 10.1 to Form 8-K filed with the Commission on June 29, 2021).
10.4		Stock and Warrant Purchase Agreement, dated effective as of August 24, 2021, among TechPrecision Corporation, Stadco New Acquisition, LLC and Five Crowns Credit Partners, LLC (incorporated herein by reference to Exhibit 10.5 to our Current Report on 8-K, filed with the Commission on August 30, 2021).*
10.5		Warrant, issued as of August 25, 2021, by TechPrecision Corporation to Five Crowns Capital, LLC (incorporated herein by reference to Exhibit 10.6 to our Current Report on 8-K, filed with the Commission on August 30, 2021).
10.7		Debt Conversion Agreement, dated as of August 25, 2021, among TechPrecision Corporation, Stadco and Douglas A. Paletz (incorporated herein by reference to Exhibit 10.7 to our Current Report on 8-K, filed with the Commission on August 30, 2021).
10.8		Debt Conversion Agreement, dated as of August 25, 2021, among TechPrecision Corporation, Stadco and Babak Parsi (incorporated herein by reference to Exhibit 10.8 to our Current Report on 8-K, filed with the Commission on August 30, 2021).
10.9		Debt Conversion Agreement, dated as of August 25 2021, among TechPrecision Corporation, Stadco and Vanguard Electronic Company (incorporated herein by reference to Exhibit 10.9 to our Current Report on 8-K, filed with the Commission on August 30, 2021).
10.10		Form of PIPE Agreement (incorporated herein by reference to Exhibit 10.10 to our Current Report on 8-K, filed with the Commission on August 30, 2021).
10.11		Amended and Restated Loan Agreement, dated as of August 25, 2021, among Ranor, Inc., Stadco New Acquisition, LLC, Westminster Credit Holdings, LLC, STADCO and Berkshire Bank (incorporated herein by reference to Exhibit 10.11 to our Current Report on 8-K, filed with the Commission on August 30, 2021).
31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1		Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS		XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

33

Table of Contents

101.SCH		XBRL Taxonomy Extension Schema Document.
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

* Pursuant to Item 601(a)(5) of Regulation S-K, certain schedules and attachments have been omitted. A copy of any omitted schedule or attachment will be furnished supplementally to the Securities and Exchange Commission upon request.

34

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		TechPrecision Corporation
December 9, 2021	By:	/s/ Thomas Sammons
		Thomas Sammons
		Chief Financial Officer

35

~~Delaware~~		~~51-0539828~~
Delaware		51-0539828
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)


1 Bella Drive
Westminster, MA		01473
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code		~~(978)~~ (978) 874-0591


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

x	~~Yes~~	¨
⌧	Yes	◻	No

x	~~Yes~~	¨
⌧	Yes	◻	No

Large accelerated filer	¨ ◻	Accelerated filer	¨ ◻
Non-accelerated filer	x ⌧	Smaller reporting company	x ☒
Emerging growth company	¨ ☐

			~~Page~~
~~PART I.~~		~~FINANCIAL INFORMATION~~	3 Page
PART I.	FINANCIAL INFORMATION	3
ITEM 1.		FINANCIAL STATEMENTS (UNAUDITED)	3
		CONDENSED CONSOLIDATED BALANCE SHEETS	3
		CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) ~~INCOME~~	4
		CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY	5
		CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS	6
		NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS	7 8
ITEM 2.		~~MANAGEMENT'S~~MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	15 22
ITEM 3.		QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK	22 31
ITEM 4.		CONTROLS AND PROCEDURES	22 32
PART II.		OTHER INFORMATION	23 33
ITEM 6.	EXHIBITS	~~EXHIBITS~~	25 33
	SIGNATURES	~~SIGNATURES~~	25 35

	December 31, 2020		March 31, 2020
ASSETS
Current assets:
Cash and cash equivalents	$	1,255,320	$	930,856
Accounts receivable, net		1,173,376		990,300
Contract assets		5,314,653		4,504,621
Raw materials		503,636		561,572
Work-in-process		694,848		656,041
Other current assets		442,024		606,151
Total current assets		9,383,857		8,249,541
Property, plant and equipment, net		4,208,329		4,182,861
Deferred income taxes		2,016,816		2,115,480
Other noncurrent assets, net		16,086		32,600
Total assets	$	15,625,088	$	14,580,482

LIABILITIES AND STOCKHOLDERS’ EQUITY:
Current liabilities:
Accounts payable	$	510,434	$	185,065
Accrued expenses		1,306,109		1,554,524
Contract liabilities		308,358		805,049
Current portion of long-term debt		3,088,553		109,829
Total current liabilities		5,213,454		2,654,467
Long-term debt		717,559		2,456,560
Commitments and contingent liabilities (Note 13)
Stockholders’ Equity:
Common stock - par value $.0001 per share, 90,000,000 shares authorized, 29,498,662 and 29,354,594 shares issued and outstanding, at December 31, 2020 and March 31, 2020		2,949		2,935
Additional paid in capital		8,911,160		8,793,062
Accumulated other comprehensive income		21,838		21,688
Retained earnings		758,128		651,770
Total stockholders’ equity		9,694,075		9,469,455
Total liabilities and stockholders’ equity	$	15,625,088	$	14,580,482

	Three Months Ended December 31,						Nine Months Ended December 31,
	2020			2019			2020			2019
Net sales	$	3,569,718		$	3,667,276		$	11,566,176		$	11,075,620
Cost of sales		2,864,274			3,352,962			9,034,858			9,238,287
Gross profit		705,444			314,314			2,531,318			1,837,333
Selling, general and administrative		716,361			662,675			2,205,739			2,145,055
(Loss) income from operations		(10,917	)		(348,361	)		325,579			(307,722	)
Other (expense) income		(219	)		185			1,237			21,063
Interest expense		(50,405	)		(69,328	)		(159,885	)		(218,447	)
Total other expense, net		(50,624	)		(69,143	)		(158,648	)		(197,384	)
(Loss) income before income taxes		(61,541	)		(417,504	)		166,931			(505,106	)
Income tax (benefit) expense		(13,369	)		(97,734	)		60,573			(115,092	)
Net (loss) income	$	(48,172	)	$	(319,770	)	$	106,358		$	(390,014	)
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments	$	1,252		$	9		$	151		$	(329	)
Other comprehensive income (loss), net of tax	$	1,252		$	9		$	151		$	(329	)
Comprehensive (loss) income	$	(46,920	)	$	(319,761	)	$	106,509		$	(390,343	)
Net (loss) income per share basic	$	(0.00	)	$	(0.01	)	$	0.00		$	(0.01	)
Net (loss) income per share diluted	$	(0.00	)	$	(0.01	)	$	0.00		$	(0.01	)
Weighted average number of shares outstanding: Basic		29,498,662			29,254,594			29,430,206			29,254,230
Diluted		29,498,662			29,254,594			31,021,384			29,254,230

	Common Stock Outstanding		Par Value		Additional Paid in Capital			Accumulated Other Comprehensive Income			Retained Earnings			Total Stockholders’ Equity
Balance 3/31/2019		29,234,594	$	2,923	$	8,693,106		$	21,940		$	993,339		$	9,711,308
Stock-based compensation						30,625									30,625
Shares issued under LTIP		20,000		2		7,198									7,200
Net income												220,777			220,777
Currency translation adjustment									(179	)					(179	)
Balance 6/30/2019		29,254,594	$	2,925	$	8,730,929		$	21,761		$	1,214,116		$	9,969,731
Stock-based compensation						30,625									30,625
Net loss												(291,021	)		(291,021	)
Currency translation adjustment									(159	)					(159	)
Balance 9/30/2019		29,254,594	$	2,925	$	8,761,554		$	21,602		$	923,095		$	9,709,176
Stock-based compensation						20,417									20,417
Net loss												(319,770	)		(319,770	)
Currency translation adjustment									9						9
Balance 12/31/2019		29,254,594	$	2,925	$	8,781,971		$	21,611		$	603,325		$	9,409,832

Balance 3/31/2020		29,354,594	$	2,935	$	8,793,062		$	21,688		$	651,770		$	9,469,455
Stock-based compensation						55,500									55,500
Shares issued under LTIP		44,068		4		(4	)								--
Net loss												(116,234	)		(116,234	)
Currency translation adjustment									(97	)					(97	)
Balance 6/30/2020		29,398,662	$	2,939	$	8,848,558		$	21,591		$	535,536		$	9,408,624
Stock-based compensation						57,417									57,417
Restricted stock award		100,000		10		133,990									134,000
Non-vested restricted stock						(134,000	)								(134,000	)
Net income												270,764			270,764
Currency translation adjustment									(1,005	)					(1,005	)
Balance 9/30/2020		29,498,662	$	2,949	$	8,905,965		$	20,586		$	806,300		$	9,735,800
Stock-based compensation						33,500									33,500
Taxes on exercised options						(28,305	)								(28,305	)
Net loss												(48,172	)		(48,172	)
Currency translation adjustment									1,252						1,252
Balance 12/31/2020		29,498,662	$	2,949	$	8,911,160		$	21,838		$	758,128		$	9,694,075

	Three months ended December 31, 2020					Three months ended December 31, 2019					Nine months ended December 31, 2020					Nine months ended December 31, 2019
Customer	Amount		Percent			Amount		Percent			Amount		Percent			Amount		Percent
A	$	398,011		11	%	$	404,062		11	%	$	2,106,998		18	%	$	1,790,311		16	%
B	$	530,583		15	%	$	*		*	%	$	1,871,256		16	%	$	*		*	%
C	$	609,114		17	%	$	1,215,737		33	%	$	1,679,814		15	%	$	2,320,485		21	%
D	$	682,337		19	%	$	727,084		20	%	$	1,631,010		14	%	$	1,825,213		16	%
E	$	550,096		15	%	$	*		*	%	$	*		*	%	$	*		*	%
F	$	*		*	%	$	*		*	%	$	*		*	%	$	1,136,146		10	%
G	$	*		*	%	$	*		*	%	$	*		*	%	$	1,148,242		10	%

Contract assets	Unbilled		Less:Progress payments		Total
December 31, 2020	$	10,074,902	$	4,760,249	$	5,314,653
March 31, 2020	$	10,635,588	$	6,130,967	$	4,504,621

Finance lease:	December 31, 2020
Property, plant and equipment	$	54,376
Accumulated depreciation		43,501
Net property, plant and equipment	$	10,875
Current portion of long-term debt	$	12,569
Long-term debt	$	1,093
Total finance lease liabilities	$	13,662

	December 31, 2020						December 31, 2019						Changes
(dollars in thousands)	Amount			Percent			Amount			Percent			Amount			Percent
Net sales	$	3,569			100	%	$	3,667			100	%	$	(98	)		(3	)%
Cost of sales		2,864			80	%		3,353			91	%		(489	)		(15	)%
Gross profit		705			20	%		314			9	%		391			124	%
Selling, general and administrative		716			20	%		663			18	%		53			8	%
Loss from operations		(11	)		-	%		(349	)		(9	)%		338			97	%
Other expense, net		(50	)		(1	)%		(69	)		(2	)%		19			28	%
Loss before taxes		(61	)		(2	)%		(418	)		(11	)%		357			85	%
Income tax benefit		(13	)		(1	)%		(98	)		(3	)%		85			87	%
Net loss	$	(48	)		(1	)%	$	(320	)		(8	)%	$	272			85	%

	December 31, 2020			December 31, 2019			$ Change			% Change
Other (expense) income, net	$	(219	)	$	185		$	(404	)		(218	)%
Interest expense	$	(36,391	)	$	(58,817	)	$	22,426			38	%
Amortization of debt issue costs	$	(14,014	)	$	(10,511	)	$	(3,503	)		(33	)%

(*dollars in thousands)*	December 31, 2020			December 31, 2019			Change Amount
Cash flows provided by (used in):
Operating activities	$	(340	)	$	609		$	(949	)
Investing activities		(547	)		(35	)		(512	)
Financing activities		1,211			(642	)		1,853
Net increase (decrease) in cash	$	324		$	(68	)	$	392